medRxiv preprint doi: https://doi.org/10.1101/2020.02.04.20020404; this version posted February 5, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license .

Epidemiological parameter review and comparative
dynamics of influenza, respiratory syncytial virus,
rhinovirus, human coronavirus, and adenovirus
Julie A. Spencer1,2, Deborah P. Shutt1, Sarah K. Moser4, Hannah Clegg1,5,
Helen J. Wearing2,3, Harshini Mukundan1, and Carrie A. Manore1∗
1

Los Alamos National Laboratory
University of New Mexico Department of Biology
University of New Mexico Department of Mathematics and Statistics
4
Bard College
5
Coastal Carolina University
∗
corresponding author
February 2, 2020
2

3

1

Introduction

Influenza-like illness (ILI) accounts for a large burden of annual morbidity and mortality worldwide (WHO
2020). Despite this, diagnostic testing for specific viruses underlying ILI is relatively rare (CDC 2019). This
results in a lack of information about the pathogens that make between 9 million and 49 million people sick
every year in the United States alone (CDC 2020). Yet knowledge of the specific diseases is necessary for
timely treatment to prevent unnecessary suffering and death (Nguyen 2016, Van Asten et al. 2012,
Pawelek et al. 2015).
ILI is defined by the CDC as fever of 100◦F and a cough and/or a sore throat without a known cause other
than influenza (CDC 2020). Defining ILI as a cluster of symptoms rather than a specific disease or diseases
is necessary for keeping track of case counts, as well as for important analysis and forecasting (Osthus and
Moran 2019). However, the cluster of symptoms known as ILI is caused by many under-lying pathogens
(Taylor 2017, Galindo-Fraga 2013). Positive diagnosis is a prerequisite for accurate treatment. To respond
to this need and to gain a finer-grained understanding of ILI that will contribute to a practical foundation
for advances in diagnostics and interventions, we here review the literature for parameter values. We then
compare the dynamics of five common upper respiratory viruses implicated in ILI: influenza, respiratory
syncytial virus (RSV), rhinovirus, human coronavirus (HCoV), and adenovirus.
We conducted a literature review to establish plausible ranges for model parameters, and developed a
deterministic system of ordinary differential equations to model the general dynamics of these five viruses.

2
2.1

Results of Parameter Literature Review
ILI Viruses

We reviewed the literature for the epidemiological parameters: incubation period, infectious period, hospitalization period, hospitalized proportion, case fatality proportion, and R0. We included results from
experimental
andreports
observational
studies,
fromby
systematic
reviews
were
NOTE: This preprint
new research
that has as
notwell
been as
certified
peer review and
shouldwhen
not bethere
used to
guideinsufficient
clinical practice.

1

medRxiv preprint doi: https://doi.org/10.1101/2020.02.04.20020404; this version posted February 5, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license
.
Spencer
et al. ILI Review page 2

Table 1: Parameters for Influenza-like illness

studies. R0 values were estimated from modeling studies. In one case, (SARS-hCoV), we included an
estimate for the infectious period, since values were lacking in the literature (Chowell 2004). We also
searched the literature for the contribution made by each of the five viruses to the total viral community in
people with ILI. Across ten study populations, at least one virus was identified in an average of 62% of
individuals with ILI symptoms. Out of these 62% of patients with ILI in whom viruses have been identiﬁed,
2

medRxiv preprint doi: https://doi.org/10.1101/2020.02.04.20020404; this version posted February 5, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license
.
Spencer
et al. ILI Review page 3

Figure 1: Viral Composition

adenovirus was identified in 8.1% of samples, human coronavirus in 8.8%, RSV in 13.5%, influenza in 21.3%,
and rhinovirus in 22.6%. Coinfection was not taken into account in these estimates.

2.2

Human Coronavirus
Table 2: Parameters for HCoV

In view of the current outbreak of novel coronavirus 2019-nCoV, and given the need for plausible parameters for modeling efforts, we conducted an in-depth literature review for human coronavirus.
3

medRxiv preprint doi: https://doi.org/10.1101/2020.02.04.20020404; this version posted February 5, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license
.
Spencer
et al. ILI Review page 4

2019-nCoV has been identified as a member of genus betacoronavirus, along with SARS and MERS
(WHO 2020). Until the genomes of 2019-nCoV have been further characterized, it seems reasonable to
suspend assumptions about the epidemiological behavior of the novel virus, and to include all known
strains in the parameter sets. Thus, our review includes values for strains 229E, NL63, OC43, HKU1,
SARS, and MERS. Means have been collected when possible; when not available, medians have been
recorded. Information on the studies, the strains, the sample sizes, and the references is available
on pages 26-27 of this paper.
We included values for R0 only for SARS and MERS, and attempted to include them only for the period
before large-scale interventions were implemented, since R0 is defined as the average number of sec-ondary
infections produced when one infected individual is introduced into a fully susceptible population (K.
Deitz, 1975). Since the seasonal strains of human coronavirus are endemic in the world, there is, by
definition, no fully susceptible population for 229E, NL63, OC43, or HKU1 in which R0 may be assessed.
Results of our review for human coronavirus include the following mean values: an incubation period
of 5.01 days, an infectious period of 15.2 days, a hospitalization period of 4.96 days, a hospitalized
proportion of 0.188, a case fatality proportion of 0.147, and an R0 of 3.7.

3
3.1

Deterministic Model
Description of Model Structure

The model diagram (Fig.1) illustrates the progression of influenza-like illness (ILI) in a human population
of a hypothetical small city containing 10,000 individuals. We assume density-dependence, that is, for a
fixed population of 10,000 humans with negligible migration, the contact rate for individuals remains
constant.
The total population (N) consists of seven classes: susceptible (S), exposed but not infectious (E), first
infectious class (I1), second infectious class (I2), hospitalized (H), recovered (R), or dead (D). Individ-uals
are considered susceptible until they contact an infectious individual from (I1), (I2), or (H). Given contact
with an infectious individual, transmission takes place with some probability. After transmission of the
virus has occurred, susceptible people move to the exposed class (E), where they spend a number of days
equal to the mean period of time between infection and the onset of infectiousness (the latent period). We
assume here that the latent period equals the incubation period, or the mean period of time between
exposure to the virus and the onset of symptoms. After the latent period, they move to the first infectious
class (I1). The mean duration of the first infectious period differs according to the underlying virus.
Symptoms worsen for some proportion of the first infectious class, who enter the hospital (H), where they
remain infectious. Individuals who do not enter the hospital remain ill outside the hospital for the duration
of the second infectious period (I2). From (I2), the length of which differs according to the underlying virus,
where we assume that the progression of the illness is not severe, individuals recover. The duration of
hospitalization differs according to the underlying virus. From the hospital, individuals either recover (R)
or die (D). We assume that hospitalized individuals have 75% less contact with susceptible individuals,
which results in 75% reduced transmission during hospitalization. We further assume that recovered
individuals (R) gain full immunity to the virus causing the illness.

4

medRxiv preprint doi: https://doi.org/10.1101/2020.02.04.20020404; this version posted February 5, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license
.
Spencer
et al. ILI Review page 5

S

E

I1

I2

R

H

D

Figure 2: Transfer diagram for ILI virus transmission.

Table 3: Descriptions of state variables
Variable

Description

S
E
I1
I2
H
R
D

Number
Number
Number
Number
Number
Number
Number

of
of
of
of
of
of
of

susceptible individuals
exposed (not infectious) individuals
initially infectious individuals
infected, non-hospitalized individuals
hospitalized individuals
recovered individuals
dead individuals

Model assumptions include:
(1) From the initially infectious state, individuals progress to hospital or continued non-hospitalized
infectious state.
(2) From the non-hospitalized infectious state, individuals progress to recovery.
(3) From the hospitalized state, individuals progress to death or recovery.
(4) Everyone who recovers gains full immunity.
(5) Total infected population = E + I1 + I2 + H.
(6) Total infectious population = I1 + I2 + H.
(7) The viruses operate independently.
(8) The population is homogeneously mixed.
(9) No demographics are included.
(10) The transmission rate for each virus is calculated from the expression for R0 below, using the mean
R0 values from the literature.

5

medRxiv preprint doi: https://doi.org/10.1101/2020.02.04.20020404; this version posted February 5, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license
.
Spencer
et al. ILI Review page 6

Table 4: Descriptions and dimensions for parameters
Parameter

Description

Dimension

β

basic transmission rate

c
γ1
γ2
γ3
γ4

reduction of transmission in hospital
per capita rate of progress from exposed to infectious state
per capita rate of progress through initial infectious state
per capita rate of progress through hospitalized state
per capita rate of progress through non-hospitalized infectious
state
proportion of initially infectious population that becomes hospitalized.
proportion of hospitalized population that die

individuals−1
time−1
dimensionless
time−1
time−1
time−1
time−1

p1
p2

3.2

dimensionless
dimensionless

Model Equations

The equations governing common upper respiratory virus dynamics are given by
dS
dt
dE
dt
dI1
dt
dI2
dt
dH
dt
dR
dt
dD
dt

= −βS(I1 + I2 + cH)

(1a)

= βS(I1 + I2 + cH) − γ1 E

(1b)

= γ1 E − γ2 I1

(1c)

= γ2 (1 − p1 )I1 − γ4 I2

(1d)

= γ2 p 1 I 1 − γ3 H

(1e)

= γ4 I2 + γ3 (1 − p2 )H

(1f)

= γ3 p 2 H

(1g)

The total population is N = S + E + I1 + I2 + H + R + D. Parameters

4
4.1

Quantities of Interest
Disease-free Equilibrium

We assume that the stable population, representing a hypothetical small city, is N = 10000. We further
assume that the initial value for the Susceptible population is S0 = 10000. In the disease-free state, all
infected classes are zero,that is, E = I1 = I2 = H = 0. Substituting and setting the derivatives equal
to zero, it is evident that in the disease-free state, the other state variables R and D will continue to
contain zero individuals, and that the Susceptible class S will remain equal to the total population N, as
follows.

6

×

medRxiv preprint doi: https://doi.org/10.1101/2020.02.04.20020404; this version posted February 5, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license
.
Spencer
et al. ILI Review page 7

dS
dt
dE
dt
dI1
dt
dI2
dt
dH
dt
dR
dt
dD
dt

= −βS(0 + 0 + c(0)) = 0

(2a)

= βS(0 + 0 + c(0)) − γ1 (0) = 0

(2b)

= γ1 (0) − γ2 (0) = 0

(2c)

= γ2 (1 − p1 )(0) − γ4 (0) = 0

(2d)

= γ2 p1 (0) − γ3 (0) = 0

(2e)

= γ4 (0) + γ3 (1 − p2 )(0) = 0

(2f)

= γ3 p2 (0) = 0

(2g)

Additionally, if we set any one of E, I1 , I2 , or H to zero, the other three state variables representing
infected classes must also be zero. In this case, N=S=10000. Thus, where x = (S, E, I1 , I2 , H, R, D)
denotes solutions of the system, xdf e = (10000, 0, 0, 0, 0, 0, 0) represents the disease-free equilibrium for
the system.

4.2

Basic Reproduction Number

Assuming a homogeneously mixed population, the basic reproductive number (R0 ) is defined as the
average number of secondary infections produced when one infected individual is introduced into a
fully susceptible population (K. Dietz, 1993). Four compartments, latently infected individuals (E),
symptomatic and infected individuals (I1 ), symptomatic and infected and non-hospitalized individuals
(I2 ), and hospitalized individuals (H), together characterize the total infected population for the ILI
virus system. To calculate R0 for this system, we derive the next generation matrix (Van den Driessche
and Watmough 2002).
Method:
1. Derive the matrix for the transmission term describing everyone entering (E): the ”F” matrix;
2. Derive the matrix for the transition terms describing everyone transitioning between infected classes
(E, I1 , I2 , H): the ”V” matrix;
3. Next Generation Matrix (NGM) = (F )(V −1 );
4. The largest dominant eigenvalue or spectral radius of the NGM = R0 for the system.
The transmission term for the system is βS(I1 + I2 + cH)


 0 βS


 0 0

F=

 0 0



0 0

βS
0
0
0

βSc 


0 



0 



0

(3)

The transmission terms for the system are (−γ1 E), (γ1 E − γ2 I1 ), (γ2 (1 − p1 )I1 − γ4 I2 ), (γ2 p1 I1 − γ3 H).

7

medRxiv preprint doi: https://doi.org/10.1101/2020.02.04.20020404; this version posted February 5, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license
.
Spencer
et al. ILI Review page 8




 γ1


 −γ

1
V=

 0



0

0

0

0 


γ2
0
0 



−γ2 (1 − p1 ) γ4 0 



−γ2 p1
0 γ3

(4)

The next generation matrix is


FV−1






=








βS( γ12

−

(p1 −1)
γ4

+

cp1
γ3 )

βS( γ12

0

−

(p1 −1)
γ4

+

cp1
γ3 )

0

βS
γ4

βSc
γ3

0

0

0

0

0

0

0

0

0

0













(5)

The spectral radius, or the largest positive eigenvalue of the next generation matrix, is the basic reproductive number of the system at the disease-free equilibrium, as follows.
R0 =

βS(cp1 γ2 γ4 − p1 γ2 γ3 + γ2 γ3 + γ3 γ4 )
γ2 γ3 γ4

(6)

This expression for the basic reproductive number (R0 ) depends on the parameters β, c, p1 , γ2 , γ3 and
γ4 , and on the initial conditions for the state variables. β is clearly directly proportional to R0 .
CONCEPTUAL METHOD OF DERIVING R0
R0 = P(arriving at I1 )(R0 while in I1 ) + P( arriving at I2 )(R0 while in I2 ) + P(arriving at H)(R0 while in H)
 

   

 
γ1
βSI2
γ1
βSHc
γ1 βSI1
+
(1 − p1 )
+
p1
R0 =
γ1
γ2
γ1
γ4
γ1
γ3

R0 =


R0 =

βSI1
γ2
βS
γ2




+ (1 − p1 )




+

βSI2
γ4

(1 − p1 )βS
γ4




+ p1


+



p1 cβS
γ3

βSHc
γ3





R0 =

βS(γ3 γ4 + (1 − p1 )γ2 γ3 + p1 cγ2 γ4)
γ2 γ3 γ4

R0 =

βS(cp1 γ2 γ4 − p1 γ2 γ3 + γ2 γ3 + γ3 γ4 )
γ2 γ3 γ4

This result is equivalent to the result obtained, above, by the next generation method.
8

medRxiv preprint doi: https://doi.org/10.1101/2020.02.04.20020404; this version posted February 5, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license
.
Spencer
et al. ILI Review page 9

5

Discussion

There are several limitations to this study. First, the model is not age-structured. Second, the assumption that the latent period equals the incubation period may result in an overestimation of the latent
period. This is because the beginning of the true infectious period may occur before the onset of symptoms; however, this is difficult to measure and is not generally reported in the studies that report values
for the incubation period. Third, a single mortality rate has been modeled for the hospitalized infected
and non-hospitalized infected classes. Fourth, many of the studies that generated parameter values evaluated populations treated at clinics or admitted at hospitals. However, a significant proportion of illness
and death may occur outside of hospitals and clinics (see Cohen et al. 2017).
Much work remains to be done to elucidate the etiology of ILI.

FUNDING STATEMENT
Research support provided by the U.S. Department of Energy through the Los Alamos National Laboratory. Los Alamos National Laboratory is operated by Triad National Security, LLC, for the National
Nuclear Security Administration of U.S. Department of Energy (Contract No. 89233218CNA000001).
LA-UR-20-21024.
JAS was partially funded by the University of New Mexico College of Arts and Sciences Dissertation
Excellence Fellowship.

6

References

Al-Tawfiq, J.A., Hinedi, K., Ghandour, J., Khairalla, H., Musleh, S., Ujayli, A. and Memish, Z.A., 2014.
Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients. Clinical
Infectious Diseases, 59(2), pp.160-165.
Alonso, W.J., Viboud, C., Simonsen, L., Hirano, E.W., Daufenbach, L.Z. and Miller, M.A., 2007. Seasonality of influenza in Brazil: a traveling wave from the Amazon to the subtropics. American journal
of epidemiology, 165(12), pp.1434-1442.
Ang, L.W., Lim, C., Lee, V.J.M., Ma, S., Tiong, W.W., Ooi, P.L., Lin, R.T.P., James, L. and Cutter, J., 2014. Influenza-associated hospitalizations, Singapore, 2004–2008 and 2010–2012. Emerging
infectious diseases, 20(10), p.1652.
Arruda, E., Pitkäranta, A.N.N.E., Witek, T.J., Doyle, C.A. and Hayden, F.G., 1997. Frequency and
natural history of rhinovirus infections in adults during autumn. Journal of clinical microbiology, 35(11),
pp.2864-2868.
Assiri, A., Al-Tawfiq, J.A., Al-Rabeeah, A.A., Al-Rabiah, F.A., Al-Hajjar, S., Al-Barrak, A., Flemban, H., Al-Nassir, W.N., Balkhy, H.H., Al-Hakeem, R.F. and Makhdoom, H.Q., 2013. Epidemiological,
demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus
disease from Saudi Arabia: a descriptive study. The Lancet infectious diseases, 13(9), pp.752-761.
Avendano, L.F., Palomino, M.A. and Larranaga, C., 2003. Surveillance for respiratory syncytial virus
in infants hospitalized for acute lower respiratory infection in Chile (1989 to 2000). Journal of clinical
microbiology, 41(10), pp.4879-4882.
Avila, PC, Abisheganaden, JA, Wong, H, Liu, J, Yagi, S, Schnurr, DS, Kishiyama, JL, Boushey, HA,
2009. Effects of allergic inflammation of the nasal mucosa on the severity of rhinovirus 16 cold. Journal
of Allergy and Clinical Immunology, 105(5), 923-931.
Bastien, N., Anderson, K., Hart, L., Caeseele, P.V., Brandt, K., Milley, D., Hatchette III, T., Weiss,
9

medRxiv preprint doi: https://doi.org/10.1101/2020.02.04.20020404; this version posted February 5, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license
.
Spencer
et al. ILI Review page 10

E.C. and Li, Y., 2005. Human coronavirus NL63 infection in Canada. The Journal of infectious diseases,
191(4), pp.503-506.
Bauch, C.T., Lloyd-Smith, J.O., Coffee, M.P. and Galvani, A.P., 2005. Dynamically modeling SARS
and other newly emerging respiratory illnesses: past, present, and future. Epidemiology, pp.791-801.
Berger, S., 2010. Infectious Diseases of Bhutan 2010 edition. ” O’Reilly Media, Inc.”.
Biggerstaff, M., Cauchemez, S., Reed, C., Gambhir, M. and Finelli, L., 2014. Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature.
BMC infectious diseases, 14(1), p.480.
Boivin, G., Baz, M., Côté, S., Gilca, R., Deffrasnes, C., Leblanc, É., Bergeron, M.G., Déry, P. and
De Serres, G., 2005. Infections by human coronavirus-NL in hospitalized children. The Pediatric infectious disease journal, 24(12), pp.1045-1048.
Bollaerts, K., Antoine, J., Van Casteren, V., Ducoffre, G., HENS, N. and Quoilin, S., 2013. Contribution of respiratory pathogens to influenza-like illness consultations. Epidemiology Infection, 141(10),
pp.2196-2204.
Bradburne, A.F., Bynoe, M.L. and Tyrrell, D.A., 1967. Effects of a” new” human respiratory virus
in volunteers. British medical journal, 3(5568), p.767.
Broor, S., Dawood, F.S., Pandey, B.G., Saha, S., Gupta, V., Krishnan, A., Rai, S., Singh, P., Erdman, D. and Lal, R.B., 2014. Rates of respiratory virus-associated hospitalization in children aged¡ 5
years in rural northern India. Journal of Infection, 68(3), pp.281-289.
Buecher, C., Mardy, S., Wang, W., Duong, V., Vong, S., Naughtin, M., Vabret, A., Freymuth, F.,
Deubel, V. and Buchy, P., 2010. Use of a multiplex PCR/RT-PCR approach to assess the viral causes
of influenza-like illnesses in Cambodia during three consecutive dry seasons. Journal of medical virology,
82(10), pp.1762-1772.
CDC, ”Glossary,” https://www.cdc.gov/flu/about/glossary.htm, accessed on 1/28/2020.
CDC, ”RSV Transmission,” https://www.cdc.gov/rsv/about/transmission.htmlȦccessed on 1/28/2020.
CDC, ”U.S. Influenza Surveillance System: Purpose and Methods”, https://www.cdc.gov/flu/weekly/overview.htm,
accessed on 1/28/2020.
Chadha, M.S., Broor, S., Gunasekaran, P., Potdar, V.A., Krishnan, A., Chawla-Sarkar, M., Biswas,
D., Abraham, A.M., Jalgaonkar, S.V., Kaur, H. and Klimov, A., 2012. Multisite virological influenza
surveillance in India: 2004–2008. Influenza and other respiratory viruses, 6(3), pp.196-203.
Chang, H.J., 2017. Estimation of basic reproduction number of the Middle East respiratory syndrome
coronavirus (MERS-CoV) during the outbreak in South Korea, 2015. Biomedical engineering online,
16(1), p.79.
Chiu, S.S., Chan, K.H., Chen, H., Young, B.W., Lim, W., Wong, W.H.S. and Peiris, J.M., 2010. Virologically confirmed population-based burden of hospitalization caused by respiratory syncytial virus,
adenovirus, and parainfluenza viruses in children in Hong Kong. The Pediatric infectious disease journal,
29(12), pp.1088-1092.
Chiu, S.S., Hung Chan, K., Wing Chu, K., Kwan, S.W., Guan, Y., Man Poon, L.L. and Peiris, J.S.M.,
2005. Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with
acute respiratory disease in Hong Kong, China. Clinical infectious diseases, 40(12), pp.1721-1729.

10

medRxiv preprint doi: https://doi.org/10.1101/2020.02.04.20020404; this version posted February 5, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license
.
Spencer
et al. ILI Review page 11

Chowell, G., Viboud, C., Simonsen, L., Miller, M. and Alonso, W.J., 2010. The reproduction number of seasonal influenza epidemics in Brazil, 1996–2006. Proceedings of the Royal Society B: Biological
Sciences, 277(1689), pp.1857-1866.
Chowell, G.M.A.M., Miller, M.A. and Viboud, C., 2008. Seasonal influenza in the United States, France,
and Australia: transmission and prospects for control. Epidemiology Infection, 136(6), pp.852-864.
Cohen, C., Walaza, S., Treurnicht, F.K., McMorrow, M., Madhi, S.A., McAnerney, J.M. and Tempia, S., 2017. In-and out-of-hospital mortality associated with seasonal and pandemic influenza and
respiratory syncytial virus in South Africa, 2009–2013. Clinical Infectious Diseases, 66(1), pp.95-103.
Commission on Acute Respiratory Diseases, 1947. Experimental transmission of minor respiratory illness
to human volunteers by filter-passing agents. I. Demonstration of two types of illness characterized by
long and short incubation periods and different clinical features. Journal of Clinical Investigation, 26(5),
pp.957-973.
Corman, V.M., Albarrak, A.M., Omrani, A.S., Albarrak, M.M., Farah, M.E., Almasri, M., Muth, D.,
Sieberg, A., Meyer, B., Assiri, A.M. and Binger, T., 2016. Viral shedding and antibody response in
37 patients with Middle East respiratory syndrome coronavirus infection. Clinical Infectious Diseases,
62(4), pp.477-483.
Couch, R.B., Gordon Douglas Jr, R., Fedson, D.S. and Kasel, J.A., 1971. Correlated studies of a
recombinant influenza-virus vaccine. III. Protection against experimental influenza in man. Journal of
Infectious Diseases, 124(5), pp.473-480.
Cowling, B.J., Fang, V.J., Riley, S., Peiris, J.M. and Leung, G.M., 2009. Estimation of the serial
interval of influenza. Epidemiology (Cambridge, Mass.), 20(3), p.344.
de Blasio, B.F., Iversen, B.G. and Tomba, G.S., 2012. Effect of vaccines and antivirals during the
major 2009 A (H1N1) pandemic wave in Norway–and the influence of vaccination timing. PLoS One,
7(1), p.e30018.
Dia, N., Sarr, F.D., Thiam, D., Sarr, T.F., Espié, E., OmarBa, I., Coly, M., Niang, M. and Richard, V.,
2014. Influenza-like illnesses in Senegal: not only focus on influenza viruses. PLoS One, 9(3), p.e93227.
Douglas Jr, R.G., Cate, T.R., Gerone, P.J. and Couch, R.B., 1966. Quantitative rhinovirus shedding
patterns in volunteers. American Review of Respiratory Disease, 94(2), pp.159-167.
Dietz, Klaus. ”The estimation of the basic reproduction number for infectious diseases.” Statistical
methods in medical research 2.1 (1993): 23-41.
Douglas, RG, Rossen, RD, Butler, WT, Couch, RB, 1967. Rhinovirus neutralizing antibody in tears,
parotid saliva, nasal secretions and serum. The Journal of Immunology, 99(2), 297-303.
Drăgănescu, A., Săndulescu, O., Florea, D., Vlaicu, O., Streinu-Cercel, A., Oţelea, D., Aramă, V.,
Luminos, M.L., Streinu-Cercel, A., Niţescu, M. and Ivanciuc, A., 2018. The influenza season 2016/17
in Bucharest, Romania–surveillance data and clinical characteristics of patients with influenza-like illness admitted to a tertiary infectious diseases hospital. Brazilian Journal of Infectious Diseases, 22(5),
pp.377-386.
Drake CL, Roehrs TA, Royer H, Koshorek G, Turner RB, Roth T, 2000. Effects of an experimentally induced rhinovirus cold on sleep, performance, and daytime alertness. Physiology and Behavior:
71(1-2), 75-81.

11

medRxiv preprint doi: https://doi.org/10.1101/2020.02.04.20020404; this version posted February 5, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license
.
Spencer
et al. ILI Review page 12

Duvvuri, V.R., Granados, A., Rosenfeld, P., Bahl, J., Eshaghi, A. and Gubbay, J.B., 2015. Genetic
diversity and evolutionary insights of respiratory syncytial virus A ON1 genotype: global and local
transmission dynamics. Scientific reports, 5, p.14268.
Falsey, A.R., Walsh, E.E. and Hayden, F.G., 2002. Rhinovirus and coronavirus infection-associated
hospitalizations among older adults. The Journal of infectious diseases, 185(9), pp.1338-1341.
Falsey, A.R., Walsh, E.E., Esser, M.T., Shoemaker, K., Yu, L. and Griffin, M.P., 2019. Respiratory
syncytial virus–associated illness in adults with advanced chronic obstructive pulmonary disease and/or
congestive heart failure. Journal of medical virology, 91(1), pp.65-71.
Fehr, A.R., Channappanavar, R. and Perlman, S., 2017. Middle East respiratory syndrome: emergence of a pathogenic human coronavirus. Annual review of medicine, 68, pp.387-399.
Feikin, D.R., Moroney, J.F., Talkington, D.F., Thacker, W.L., Code, J.E., Schwartz, L.A., Erdman,
D.D., Butler, J.C. and Cetron, M.S., 1999. An outbreak of acute respiratory disease caused by Mycoplasma pneumoniae and adenovirus at a federal service training academy: new implications from an
old scenario. Clinical infectious diseases, pp.1545-1550.
Fica, A., Dabanch, J., Andrade, W., Bustos, P., Carvajal, I., Ceroni, C., Triantalo, V., Castro, M. and
Fasce, R., 2015. Clinical relevance of rhinovirus infections among adult hospitalized patients. Brazilian
Journal of Infectious Diseases, 19(2), pp.118-124.
Fowlkes, A., Giorgi, A., Erdman, D., Temte, J., Goodin, K., Di Lonardo, S., Sun, Y., Martin, K.,
Feist, M., Linz, R. and Boulton, R., 2013. Viruses associated with acute respiratory infections and
influenza-like illness among outpatients from the Influenza Incidence Surveillance Project, 2010–2011.
The Journal of infectious diseases, 209(11), pp.1715-1725.
Freymuth, F., Vabret, A., Rozenberg, F., Dina, J., Petitjean, J., Gouarin, S., Legrand, L., Corbet,
S., Brouard, J. and Lebon, P., 2005. Replication of respiratory viruses, particularly influenza virus,
rhinovirus, and coronavirus in HuH7 hepatocarcinoma cell line. Journal of medical virology, 77(2),
pp.295-301.
Fritz, R.S., Hayden, F.G., Calfee, D.P., Cass, L.M., Peng, A.W., Alvord, W.G., Strober, W. and Straus,
S.E., 1999. Nasal cytokine and chemokine responses in experimental influenza A virus infection: results
of a placebo-controlled trial of intravenous zanamivir treatment. The Journal of infectious diseases,
180(3), pp.586-593.
Gadsby, N. J. and Templeton, K. E. Coronaviruses. In P. R. Murray, E. J. Baron, J. Jorgensen, M.
Pfaller M. L. Landry (Eds.), Manual of Clinical Microbiology (9th ed., pp. 1414) ASM Press.
Galindo-Fraga, A., Ortiz-Hernández, A.A., Ramı́rez-Venegas, A., Vázquez, R.V., Moreno-Espinosa, S.,
Llamosas-Gallardo, B., Pérez-Patrigeon, S., Salinger, M., Freimanis, L., Huang, C.Y. and Gu, W., 2013.
Clinical characteristics and outcomes of influenza and other influenza-like illnesses in Mexico City. International Journal of Infectious Diseases, 17(7), pp.e510-e517.
Gerber, S.I., Erdman, D.D., Pur, S.L., Diaz, P.S., Segreti, J., Kajon, A.E., Belkengren, R.P. and Jones,
R.C., 2001. Outbreak of adenovirus genome type 7d2 infection in a pediatric chronic-care facility and
tertiary-care hospital. Clinical infectious diseases, 32(5), pp.694-700.
Graat, J.M., Schouten, E.G., Heijnen, M.L.A., Kok, F.J., Pallast, E.G., de Greeff, S.C. and DorigoZetsma, J.W., 2003. A prospective, community-based study on virologic assessment among elderly people with and without symptoms of acute respiratory infection. Journal of clinical epidemiology, 56(12),
pp.1218-1223.

12

medRxiv preprint doi: https://doi.org/10.1101/2020.02.04.20020404; this version posted February 5, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license
.
Spencer
et al. ILI Review page 13

Hall, C.B., Long, C.E. and Schnabel, K.C., 2001. Respiratory syncytial virus infections in previously
healthy working adults. Clinical infectious diseases, 33(6), pp.792-796.
Harris JM, Gwaltney JM, 1996. Incubation periods of experimental rhinovirus infection and illness.
Clinical Infectious Diseases: 23, 1287-90. Hilleman, M.R., Gauld, R.L., BUTLEB, R., Stallones, R.A.,
Hedberg, C.L., Warfield, M.S. and Anderson, S.A., 1957. Appraisal of occurrence of adenovirus-caused
respiratory illness in military populations. American journal of hygiene, 66(1), pp.29-41.
Hong, J.Y., Lee, H.J., Piedra, P.A., Choi, E.H., Park, K.H., Koh, Y.Y. and Kim, W.S., 2001. Lower
respiratory tract infections due to adenovirus in hospitalized Korean children: epidemiology, clinical
features, and prognosis. Clinical infectious diseases, 32(10), pp.1423-1429.
Howard, T.S., Hoffman, L.H., Stang, P.E. and Simoes, E.A., 2000. Respiratory syncytial virus pneumonia in the hospital setting: length of stay, charges, and mortality. The Journal of pediatrics, 137(2),
pp.227-232.
Iwane, M.K., Edwards, K.M., Szilagyi, P.G., Walker, F.J., Griffin, M.R., Weinberg, G.A., Coulen, C.,
Poehling, K.A., Shone, L.P., Balter, S. and Hall, C.B., 2004. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among
young children. Pediatrics, 113(6), pp.1758-1764.
Iwane, M.K., Prill, M.M., Lu, X., Miller, E.K., Edwards, K.M., Hall, C.B., Griffin, M.R., Staat, M.A.,
Anderson, L.J., Williams, J.V. and Weinberg, G.A., 2011. Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. Journal of Infectious Diseases, 204(11),
pp.1702-1710.
Johnson KM, Chanock RM, Rifkind D, Dravetz HM, Knight V. 1961. Respiratory syncytial virus
infection in adult volunteers. J.A.M.A. 176:663-677, 1961.
Kaiser, L., Briones, M.S. and Hayden, F.G., 1999. Performance of virus isolation and Directigen R
Flu A to detect influenza A virus in experimental human infection. Journal of clinical virology, 14(3),
pp.191-197.
Kaiser, L., Regamey, N., Roiha, H., Deffernez, C. and Frey, U., 2005. Human coronavirus NL63 associated with lower respiratory tract symptoms in early life. The Pediatric infectious disease journal,
24(11), pp.1015-1017.
Kessaram, T., Stanley, J. and Baker, M.G., 2015. Estimating influenza-associated mortality in New
Zealand from 1990 to 2008. Influenza and other respiratory viruses, 9(1), pp.14-19.
Kim, H.W., Brandt, C.D., Arrobio, J.O., Murphy, B., Chanock, R.M. and Parrott, R.H., 1979. Influenza A and B virus infection in infants and young children during the years 1957–1976. American
Journal of Epidemiology, 109(4), pp.464-479.
Kim, Y., Lee, S., Chu, C., Choe, S., Hong, S. and Shin, Y., 2016. The characteristics of Middle
Eastern respiratory syndrome coronavirus transmission dynamics in South Korea. Osong public health
and research perspectives, 7(1), pp.49-55.
Ko, J.H., Woo, H.T., Oh, H.S., Moon, S.M., Choi, J.Y., Lim, J.U., Kim, D., Byun, J., Kwon, S.H.,
Kang, D. and Heo, J.Y., 2019. Ongoing outbreak of human adenovirus-associated acute respiratory
illness in the Republic of Korea military, 2013 to 2018. Korean J Intern Med, 34(5), pp.1171-1171.
Kondo, S. and Abe, K., 1991. The effects of influenza virus infection on FEV1 in asthmatic children:
the time-course study. Chest, 100(5), pp.1235-1238.

13

medRxiv preprint doi: https://doi.org/10.1101/2020.02.04.20020404; this version posted February 5, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license
.
Spencer
et al. ILI Review page 14

Laguna-Torres, V.A., Gómez, J., Ocaña, V., Aguilar, P., Saldarriaga, T., Chavez, E., Perez, J., Zamalloa, H., Forshey, B., Paz, I. and Gomez, E., 2009. Influenza-like illness sentinel surveillance in Peru.
PloS one, 4(7), p.e6118.
Landry, Marie Louise. Rhinoviruses. In P. R. Murray, E. J. Baron, J. Jorgensen, M. Pfaller M. L.
Landry (Eds.), Manual of Clinical Microbiology (9th ed., pp. 1405) ASM Press.
Larrañaga, C., Martı́nez, J., Palomino, A., Peña, M. and Carrión, F., 2007. Molecular characterization of hospital-acquired adenovirus infantile respiratory infection in Chile using species-specific PCR
assays. Journal of clinical virology, 39(3), pp.175-181.
Lee, N., Qureshi, S.T., Other viral pneumonias. Crit Care Clin 29 (2013) 1045–1068.
Lee, W.M., Lemanske Jr, R.F., Evans, M.D., Vang, F., Pappas, T., Gangnon, R., Jackson, D.J. and
Gern, J.E., 2012. Human rhinovirus species and season of infection determine illness severity. American
journal of respiratory and critical care medicine, 186(9), pp.886-891.
Lessler, J., Reich, N.G., Brookmeyer, R., Perl, T.M., Nelson, K.E. and Cummings, D.A., 2009. Incubation periods of acute respiratory viral infections: a systematic review. The Lancet infectious diseases,
9(5), pp.291-300.
Leung, G.M., Chung, P.H., Tsang, T., Lim, W., Chan, S.K., Chau, P., Donnelly, C.A., Ghani, A.C.,
Fraser, C., Riley, S. and Ferguson, N.M., 2004. SARS-CoV antibody prevalence in all Hong Kong patient
contacts. Emerging infectious diseases, 10(9), p.1653.
Levy, N., Iv, M. and Yom-Tov, E., 2018. Modeling influenza-like illnesses through composite compartmental models. Physica A: Statistical Mechanics and its Applications, 494, pp.288-293.
Lipsitch, M., Cohen, T., Cooper, B., Robins, J.M., Ma, S., James, L., Gopalakrishna, G., Chew, S.K.,
Tan, C.C., Samore, M.H. and Fisman, D., 2003. Transmission dynamics and control of severe acute
respiratory syndrome. Science, 300(5627), pp.1966-1970
Louie, J.K., Hacker, J.K., Gonzales, R., Mark, J., Maselli, J.H., Yagi, S. and Drew, W.L., 2005. Characterization of viral agents causing acute respiratory infection in a San Francisco University Medical
Center Clinic during the influenza season. Clinical Infectious Diseases, 41(6), pp.822-828.
Mahony, J.B., Petrich, A. and Smieja, M., 2011. Molecular diagnosis of respiratory virus infections.
Critical reviews in clinical laboratory sciences, 48(5-6), pp.217-249.
Majumder, M.S., Rivers, C., Lofgren, E. and Fisman, D., 2014. Estimation of MERS-coronavirus reproductive number and case fatality rate for the spring 2014 Saudi Arabia outbreak: insights from publicly
available data. PLoS currents, 6.
Mendez-Dominguez, N.I., Bobadilla-Rosado, L.O., Fajardo-Ruiz, L.S., Camara-Salazar, A. and GomezCarro, S., 2019. Influenza in Yucatan in 2018: Chronology, characteristics and outcomes of ambulatory
and hospitalized patients. Brazilian Journal of Infectious Diseases, 23(5), pp.358-362.
Miller, E.K., Linder, J., Kraft, D., Johnson, M., Lu, P., Saville, B.R., Williams, J.V., Griffin, M.R.
and Talbot, H.K., 2016. Hospitalizations and outpatient visits for rhinovirus-associated acute respiratory illness in adults. Journal of Allergy and Clinical Immunology, 137(3), pp.734-743.
Millman, A. J., Reed, C., Kirley, P., Aragon, D., Meek, J. I., Farley, M. M....Chaves, S. (2015). Improving Accuracy of Influenza-Associated Hospitalization Rate Estimates. Emerging Infectious Diseases,
21(9), 1595-1601. https://dx.doi.org/10.3201/eid

14

medRxiv preprint doi: https://doi.org/10.1101/2020.02.04.20020404; this version posted February 5, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license
.
Spencer
et al. ILI Review page 15

Morrow, B.M., Hatherill, M., Smuts, H.E., Yeats, J., Pitcher, R. and Argent, A.C., 2006. Clinical
course of hospitalised children infected with human metapneumovirus and respiratory syncytial virus.
Journal of paediatrics and child health, 42(4), pp.174-178.
Moser, M.R., Bender, T.R., Margolis, H.S., Noble, G.R., Kendal, A.P. and Ritter, D.G., 1979. An
outbreak of influenza aboard a commercial airliner. American journal of epidemiology, 110(1), pp.1-6.
Mullooly, J.P., Bridges, C.B., Thompson, W.W., Chen, J., Weintraub, E., Jackson, L.A., Black, S.,
Shay, D.K. and Vaccine Safety Datalink Adult Working Group, 2007. Influenza-and RSV-associated
hospitalizations among adults. Vaccine, 25(5), pp.846-855.
Naclerio RM, Proud D, Lichtenstein LM, Kagey-Sobotka A, Hendley JO,, Sorrentino J, Gwaltney JM,
1987. Kinins are generated during experimental rhinovirus colds. Th Journal of Infectious Diseases:
157(1), 133-142.
Nandi, T., Khanna, M., Pati, D.R., Kumar, B. and Singh, V., 2018. Epidemiological surveillance and
comparative analysis of patients with influenza like illness and other respiratory viruses. International
Journal of Infectious Diseases, 73, p.203.
Nguyen, D.N.T., Bryant, J.E., Hang, N.L.K., Nadjm, B., Thai, P.Q., Duong, T.N., Anh, D.D., Horby,
P., van Doorn, H.R., Wertheim, H.F. and Fox, A., 2016. Epidemiology and etiology of influenza-likeillness in households in Vietnam; it’s not all about the kids!. Journal of Clinical Virology, 82, pp.126-132.
Nicholson, K.G., Kent, J., Hammersley, V. and Cancio, E., 1996. Risk factors for lower respiratory
complications of rhinovirus infections in elderly people living in the community: prospective cohort
study. Bmj, 313(7065), pp.1119-1123.
Oner, A.F., Bay, A., Arslan, S., Akdeniz, H., Sahin, H.A., Cesur, Y., Epcacan, S., Yilmaz, N., Deger,
I., Kizilyildiz, B. and Karsen, H., 2006. Avian influenza A (H5N1) infection in eastern Turkey in 2006.
New England Journal of Medicine, 355(21), pp.2179-2185.
Osthus, D. and Moran, K. R., Multiscale influenza forecasting, 2019. arXiv:1909.13766v1 [stat.AP]
30 Sep 2019.
Peled, N., Nakar, C., Huberman, H., Scherf, E., Samra, Z., Finkelstein, Y., Hoffer, V. and Garty,
B.Z., 2004. Adenovirus infection in hospitalized immunocompetent children. Clinical pediatrics, 43(3),
pp.223-229.
Pitzer, V.E., Viboud, C., Alonso, W.J., Wilcox, T., Metcalf, C.J., Steiner, C.A., Haynes, A.K. and
Grenfell, B.T., 2015. Environmental drivers of the spatiotemporal dynamics of respiratory syncytial
virus in the United States. PLoS pathogens, 11(1), p.e1004591.
Pringle, C.R., Filipiuk, A.H., Robinson, B.S., Watt, P.J., Higgins, P. and Tyrrell, D.A.J., 1993. Immunogenicity and pathogenicity of a triple temperature-sensitive modified respiratory syncytial virus in
adult volunteers. Vaccine, 11(4), pp.473-478.
Quandelacy, T.M., Viboud, C., Charu, V., Lipsitch, M. and Goldstein, E., 2013. Age-and sex-related
risk factors for influenza-associated mortality in the United States between 1997–2007. American journal
of epidemiology, 179(2), pp.156-167.
Ramadan, N. and Shaib, H. (2019) ‘Middle East respiratory syndrome coronavirus (MERS-CoV): A
review’, Germs, 9(1), pp. 35-42.
Reich NG, Perl TM, Cummings DAT, Lessler J, 2011. Visualizing clinical evidence: citation networks
for the incubation periods of respiratory viral infections. PLoS One 6(4), 1-6.

15

medRxiv preprint doi: https://doi.org/10.1101/2020.02.04.20020404; this version posted February 5, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license
.
Spencer
et al. ILI Review page 16

Reina, J., López-Causapé, C., Rojo-Molinero, E. and Rubio, R., 2014. Clinico-epidemiological characteristics of acute respiratory infections by coronavirus OC43, NL63 and 229E. Revista Clı́nica Española
(English Edition), 214(9), pp.499-504.
Reis J., Shaman, J., 2016. RetrospectiveParameterEstimationand Forecastof RespiratorySyncytialVirusin
the UnitedStates.PLoSComputBiol 12(10):e1005133.doi:10.1371/journal.pcbi.1005133
Reis, J. and Shaman, J., 2018. Simulation of four respiratory viruses and inference of epidemiological parameters. Infectious Disease Modelling, 3, pp.23-34.
Riley, S., Fraser, C., Donnelly, C.A., Ghani, A.C., Abu-Raddad, L.J., Hedley, A.J., Leung, G.M., Ho,
L.M., Lam, T.H., Thach, T.Q. and Chau, P., 2003. Transmission dynamics of the etiological agent of
SARS in Hong Kong: impact of public health interventions. Science, 300(5627), pp.1961-1966.
Robinson, C., Echavarria, M. (2007). Adenoviruses. In P. R. Murray, E. J. Baron, J. Jorgensen,
M. Pfaller M. L. Landry (Eds.), Manual of Clinical Microbiology (9th ed., pp. 1589) ASM Press.
Sansone, M., Wiman, Å., Karlberg, M.L., Brytting, M., Bohlin, L., Andersson, L.M., Westin, J. and
Nordén, R., 2019. Molecular characterization of a nosocomial outbreak of influenza B virus in an acute
care hospital setting. Journal of Hospital Infection, 101(1), pp.30-37.
Scully, E.J., Basnet, S., Wrangham, R.W., Muller, M.N., Otali, E., Hyeroba, D., Grindle, K.A., Pappas,
T.E., Thompson, M.E., Machanda, Z. and Watters, K.E., 2018. Lethal respiratory disease associated
with human rhinovirus C in wild chimpanzees, Uganda, 2013. Emerging infectious diseases, 24(2), p.267.
Sendra-Gutiérrez, J.M., Martı́n-Rios, D., Casas, I., Sáez, P., Tovar, A. and Moreno, C., 2004. An
outbreak of adenovirus type 8. Euro Surveill, 9(3), pp.27-30.
Sentilhes, A.C., Choumlivong, K., Celhay, O., Sisouk, T., Phonekeo, D., Vongphrachanh, P., Brey,
P. and Buchy, P., 2013. Respiratory virus infections in hospitalized children and adults in Lao PDR.
Influenza and other respiratory viruses, 7(6), pp.1070-1078.
Shay, D.K., Holman, R.C., Newman, R.D., Liu, L.L., Stout, J.W. and Anderson, L.J., 1999. Bronchiolitisassociated hospitalizations among US children, 1980-1996. Jama, 282(15), pp.1440-1446.
Sonthichai, C., Iamsirithaworn, S., Cummings, D.A.T., Shokekird, P., Niramitsantipong, A., Khumket,
S., Chittaganpitch, M. and Lessler, J., 2011. Effectiveness of non-pharmaceutical interventions in controlling an influenza A outbreak in a school, Thailand, November 2007. Outbreak, surveillance and
investigation reports, 4(2), pp.6-11.
Tam, P.Y.I., Zhang, L. and Cohen, Z., 2018. Clinical characteristics and outcomes of human rhinovirus
positivity in hospitalized children. Annals of thoracic medicine, 13(4), p.230.
Tanz, R.R. ”Sore Throat”, Kliegman, R.M., Lye, P.S., Bordini, B.J., Toth, H. and Basel, D., 2017.
Nelson Pediatric Symptom-Based Diagnosis E-Book. Elsevier Health Sciences.
Taylor, S., Lopez, P., Weckx, L., Borja-Tabora, C., Ulloa-Gutierrez, R., Lazcano-Ponce, E., Kerdpanich,
A., Weber, M.A.R., de Los Santos, A.M., Tinoco, J.C. and Safadi, M.A.P., 2017. Respiratory viruses
and influenza-like illness: epidemiology and outcomes in children aged 6 months to 10 years in a multicountry population sample. Journal of Infection, 74(1), pp.29-41.
Tsolia, M.N., Kafetzis, D., Danelatou, K., Astra, H., Kallergi, K., Spyridis, P. and Karpathios, T.E.,
2003. Epidemiology of respiratory syncytial virus bronchiolitis in hospitalized infants in Greece. European journal of epidemiology, 18(1), pp.55-61.

16

medRxiv preprint doi: https://doi.org/10.1101/2020.02.04.20020404; this version posted February 5, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license
.
Spencer
et al. ILI Review page 17

Tyrell, D.A.J., Cohen, S. and Schilarb, J.E., 1993. Signs and symptoms in common colds. Epidemiology
Infection, 111(1), pp.143-156.
Valtonen, M., Waris, M., Vuorinen, T., Eerola, E., Hakanen, A.J., Mjosund, K., Grönroos, W., Heinonen,
O.J. and Ruuskanen, O., 2019. Common cold in Team Finland during 2018 Winter Olympic Games
(PyeongChang): epidemiology, diagnosis including molecular point-of-care testing (POCT) and treatment. British journal of sports medicine, 53(17), pp.1093-1098.
Van Asten, L., van den Wijngaard, C., van Pelt, W., van de Kassteele, J., Meijer, A., van der Hoek, W.,
Kretzschmar, M. and Koopmans, M., 2012. Mortality attributable to 9 common infections: significant
effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly
persons. The Journal of infectious diseases, 206(5), pp.628-639.
Van Beek, J., Veenhoven, R.H., Bruin, J.P., Van Boxtel, R.A., de Lange, M.M., Meijer, A., Sanders,
E.A., Rots, N.Y. and Luytjes, W., 2017. Influenza-like illness incidence is not reduced by influenza
vaccination in a cohort of older adults, despite effectively reducing laboratory-confirmed influenza virus
infections. The Journal of infectious diseases, 216(4), pp.415-424.
Van den Driessche, P. and Watmough, J., 2002. Reproduction numbers and sub-threshold endemic
equilibria for compartmental models of disease transmission. Mathematical biosciences, 180(1-2), pp.2948.
Van Gageldonk-Lafeber, A.B., Heijnen, M.L.A., Bartelds, A.I., Peters, M.F., van der Plas, S.M. and
Wilbrink, B., 2005. A case-control study of acute respiratory tract infection in general practice patients
in The Netherlands. Clinical Infectious Diseases, 41(4), pp.490-497.
Varghese, B.M., Dent, E., Chilver, M., Cameron, S. and Stocks, N.P., 2018. Epidemiology of viral
respiratory infections in Australian working-age adults (20–64 years): 2010–2013. Epidemiology Infection, 146(5), pp.619-626.
Velasco-Hernández, J.X., Núñez-López, M., Comas-Garcı́a, A., Cherpitel, D.E.N. and Ocampo, M.C.,
2015. Superinfection between influenza and RSV alternating patterns in San Luis potosı́ state, México.
PloS one, 10(3), p.e0115674.
Virlogeux, V., Park, M., Wu, J.T. and Cowling, B.J., 2016. Association between severity of MERSCoV infection and incubation period. Emerging infectious diseases, 22(3), p.526.
Wallinga, J. and Lipsitch, M., 2006. How generation intervals shape the relationship between growth
rates and reproductive numbers. Proceedings of the Royal Society B: Biological Sciences, 274(1609),
pp.599-604.
Wat, D., 2004. The common cold: a review of the literature. European Journal of Internal Medicine,
15(2), pp.79-88.
Weber, A., Weber, M. and Milligan, P., 2001. Modeling epidemics caused by respiratory syncytial
virus (RSV). Mathematical biosciences, 172(2), pp.95-113.
Welliver Sr, R.C., Checchia, P.A., Bauman, J.H., Fernandes, A.W., Mahadevia, P.J. and Hall, C.B.,
2010. Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy
children. Current medical research and opinion, 26(9), pp.2175-2181.
Wesley, A.G., Pather, M. and Tait, D., 1993. Nosocomial adenovirus infection in a paediatric respiratory unit. Journal of Hospital Infection, 25(3), pp.183-190.

17

medRxiv preprint doi: https://doi.org/10.1101/2020.02.04.20020404; this version posted February 5, 2020. The copyright holder for this
preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in
perpetuity.
It is made available under a CC-BY-NC 4.0 International license
.
Spencer
et al. ILI Review page 18

WHO, ”Influenza Burden of Disease,” https://www.who.int/influenza/surveillance monitoring/bod/en/.
Accessed on 1/28/2020.

WHO, ”MERS Situation Update, November 2019,” accessed on January 30, 2020. http://applications.emro.who.int/docs/
CSR-241-2019-EN.pdf?ua=1ua=1ua=1
Zaas, A.K., Chen, M., Varkey, J., Veldman, T., Hero III, A.O., Lucas, J., Huang, Y., Turner, R.,
Gilbert, A., Lambkin-Williams, R. and Øien, N.C., 2009. Gene expression signatures diagnose influenza
and other symptomatic respiratory viral infections in humans. Cell host & microbe, 6(3), pp.207-217.

18

ILI Parameter Ranges and Means

Spencer et al. ILI Review page 19

Spencer et al. ILI Review page 20
INFLUENZA parameters: incubation period, infectious period, hospitalization period, hospitalization proportion, case fatality, R0
parameter
(Influenza A & B)
incubation period

type of study

experimental

experimental

experimental

study time

30 days

8 days

49 days

population

healthy adults

healthy males

male inmates

sample size strain

definition of

17

seasonal

inoculation to peak
symptoms

16

FluA (H1N1)

inoculation to
occurrence of
symptoms

43

FluA (Hong
Kong)

inoculation to onset

observational

admitted to
hospital

8

seasonal

exposure to onset

observational

airline passengers

54

FluA(H5N1)

airline delay to onset

healthy adults

14

FluA(H1N1)

inoculation to onset

asthmatic children

20

NA

experimental

8 days

observational
systematic
review
review

method

exposed to
diseased/dead
chickens

inoculation to onset of
symptoms
before 2004

notes

patient age range

mean

adult

2-4 days,
median 3.3

3 days

19-35

1-3 days

2 days

21-40

2-3 days

2.5 days

5--15

3.7-6.3 days

5 days

1-3 days

1.5 days

19-40

2-3 days

2.5 days

43689

2-3 days

2.5 days

1-4 days

2 days

1-4 days

2.5

range and
central tendency all

literature

citation

Zaas, A.K., Chen, M., Varkey, J., Veldman, T., Hero III, A.O., Lucas, J., Huang, Y., Turner, R., Gilbert, A.,
Lambkin-Williams, R. and Øien, N.C., 2009. Gene expression signatures diagnose influenza and other
symptomatic respiratory viral infections in humans. Cell host & microbe, 6(3), pp.207-217.
Fritz, R.S., Hayden, F.G., Calfee, D.P., Cass, L.M., Peng, A.W., Alvord, W.G., Strober, W. and Straus,
S.E., 1999. Nasal cytokine and chemokine responses in experimental influenza A virus infection:
results of a placebo-controlled trial of intravenous zanamivir treatment. The Journal of infectious
diseases, 180(3), pp.586-593.
Couch, R.B., Gordon Douglas Jr, R., Fedson, D.S. and Kasel, J.A., 1971. Correlated studies of a
recombinant influenza-virus vaccine. III. Protection against experimental influenza in man. Journal of
Infectious Diseases, 124(5), pp.473-480.
Oner, A.F., Bay, A., Arslan, S., Akdeniz, H., Sahin, H.A., Cesur, Y., Epcacan, S., Yilmaz, N., Deger, I.,
Kizilyildiz, B. and Karsen, H., 2006. Avian influenza A (H5N1) infection in eastern Turkey in 2006. New
England Journal of Medicine, 355(21), pp.2179-2185.
Moser, M.R., Bender, T.R., Margolis, H.S., Noble, G.R., Kendal, A.P. and Ritter, D.G., 1979. An outbreak
of influenza aboard a commercial airliner. American journal of epidemiology, 110(1), pp.1-6.
Kaiser, L., Briones, M.S. and Hayden, F.G., 1999. Performance of virus isolation and Directigen® Flu A
to detect influenza A virus in experimental human infection. Journal of clinical virology, 14(3), pp.191197.
Kondo, S. and Abe, K., 1991. The effects of influenza virus infection on FEV1 in asthmatic children: the
time-course study. Chest, 100(5), pp.1235-1238.
REVIEW: Lessler, J., Reich, N.G., Brookmeyer, R., Perl, T.M., Nelson, K.E. and Cummings, D.A., 2009.
Incubation periods of acute respiratory viral infections: a systematic review. The Lancet infectious
diseases, 9(5), pp.291-300.
REVIEW: Wat, D., 2004. The common cold: a review of the literature. European Journal of Internal
Medicine, 15(2), pp.79-88.

infectious period

experimental

experimental

8 days

49 days

healthy males

FluA(H1N1)

male inmates

FluA (Hong
Kong)

virus titer

experimental
14 days
observational

experimental

1 year

ferrets

8

FluA(H1N1)

culture + RTPCR, titer

index contacts

350

seasonal

culture + RT-PCR

otherwise healthy
ILI children

observational

1975-1995

healthy adults

observational

31 days
(2016)

confirmed FluB
outbreak in
hospital

retrospective

19 years

respiratory disease
patients

seasonal
59

seasonal

mean duration of
illness

mean viral
shedding period
4.6 days
19-35

3.1-5.7 days

4.6 days

21-40

2-9 days

5.5 days

19-40

1-8 days

4.5 days

2 days

2 days

all

2 days

6 months-10
yrs

8.9 days

adult

6.8 days

Fritz, R.S., Hayden, F.G., Calfee, D.P., Cass, L.M., Peng, A.W., Alvord, W.G., Strober, W. and Straus,
S.E., 1999. Nasal cytokine and chemokine responses in experimental influenza A virus infection:
results of a placebo-controlled trial of intravenous zanamivir treatment. The Journal of infectious
diseases, 180(3), pp.586-593.
Couch, R.B., Gordon Douglas Jr, R., Fedson, D.S. and Kasel, J.A., 1971. Correlated studies of a
recombinant influenza-virus vaccine. III. Protection against experimental influenza in man. Journal of
Infectious Diseases, 124(5), pp.473-480.
Kaiser, L., Briones, M.S. and Hayden, F.G., 1999. Performance of virus isolation and Directigen® Flu A
to detect influenza A virus in experimental human infection. Journal of clinical virology, 14(3), pp.191197.

Cowling, B.J., Fang, V.J., Riley, S., Peiris, J.M. and Leung, G.M., 2009. Estimation of the serial interval
of influenza. Epidemiology (Cambridge, Mass.), 20(3), p.344.
Taylor, S., Lopez, P., Weckx, L., Borja-Tabora, C., Ulloa-Gutierrez, R., Lazcano-Ponce, E., Kerdpanich,
A., Weber, M.A.R., de Los Santos, A.M., Tinoco, J.C. and Safadi, M.A.P., 2017. Respiratory viruses and
influenza-like illness: epidemiology and outcomes in children aged 6 months to 10 years in a multicountry population sample. Journal of Infection, 74(1), pp.29-41.
Hall, C.B., Long, C.E. and Schnabel, K.C., 2001. Respiratory syncytial virus infections in previously
healthy working adults. Clinical infectious diseases, 33(6), pp.792-796.

hospitalization
period

observational

2016-2017

ILI patients

experimental

1 year

otherwise healthy
ILI children

mean length of hosp.
stay

11.3 days

0-72 months

all

seasonal

6 months-10
yrs

8 days

4-6 days

5 days

4 days

Sansone, M., Wiman, Å., Karlberg, M.L., Brytting, M., Bohlin, L., Andersson, L.M., Westin, J. and Nordén,
R., 2019. Molecular characterization of a nosocomial outbreak of influenza B virus in an acute care
hospital setting. Journal of Hospital Infection, 101(1), pp.30-37.
Kim, H.W., Brandt, C.D., Arrobio, J.O., Murphy, B., Chanock, R.M. and Parrott, R.H., 1979. Influenza A
and B virus infection in infants and young children during the years 1957–1976. American Journal of
Epidemiology, 109(4), pp.464-479.
Drăgănescu, A., Săndulescu, O., Florea, D., Vlaicu, O., Streinu-Cercel, A., Oţelea, D., Aramă, V.,
Luminos, M.L., Streinu-Cercel, A., Niţescu, M. and Ivanciuc, A., 2018. The influenza season 2016/17 in
Bucharest, Romania–surveillance data and clinical characteristics of patients with influenza-like illness
admitted to a tertiary infectious diseases hospital. Brazilian Journal of Infectious Diseases, 22(5),
pp.377-386.
Taylor, S., Lopez, P., Weckx, L., Borja-Tabora, C., Ulloa-Gutierrez, R., Lazcano-Ponce, E., Kerdpanich,
A., Weber, M.A.R., de Los Santos, A.M., Tinoco, J.C. and Safadi, M.A.P., 2017. Respiratory viruses and
influenza-like illness: epidemiology and outcomes in children aged 6 months to 10 years in a multicountry population sample. Journal of Infection, 74(1), pp.29-41.

Spencer et al. ILI Review page 21

observational

2009-2011

children <5

median length of
hospital stay

17

<5

3-4 days

3.5 days

Broor, S., Dawood, F.S., Pandey, B.G., Saha, S., Gupta, V., Krishnan, A., Rai, S., Singh, P., Erdman, D.
and Lal, R.B., 2014. Rates of respiratory virus-associated hospitalization in children aged< 5 years in
rural northern India. Journal of Infection, 68(3), pp.281-289.

hospitalization
proportion

observational

2009-2011

children <5 in India 245

numer hospitalized out
of 10,000

retrospective,
adjusted

2003-2013

all population

number hospitalized
out of 100,000

observational

2004-2008

all population

number hospitalized
out of 100,000

<6 months≥75 yrs

0.00028

observational

2010-2012

all population

number hospitalized
out of 100,000

<6 months≥75 yrs

0.0003

Iwane, M.K., Edwards, K.M., Szilagyi, P.G., Walker, F.J., Griffin, M.R., Weinberg, G.A., Coulen, C.,
Poehling, K.A., Shone, L.P., Balter, S. and Hall, C.B., 2004. Population-based surveillance for
hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses
among young children. Pediatrics, 113(6), pp.1758-1764.
Broor, S., Dawood, F.S., Pandey, B.G., Saha, S., Gupta, V., Krishnan, A., Rai, S., Singh, P., Erdman, D.
and Lal, R.B., 2014. Rates of respiratory virus-associated hospitalization in children aged< 5 years in
rural northern India. Journal of Infection, 68(3), pp.281-289.
Millman, A. J., Reed, C., Kirley, P., Aragon, D., Meek, J. I., Farley, M. M....Chaves, S. (2015). Improving
Accuracy of Influenza-Associated Hospitalization Rate Estimates. Emerging Infectious Diseases, 21(9),
1595-1601. https://dx.doi.org/10.3201/eid
Ang, L.W., Lim, C., Lee, V.J.M., Ma, S., Tiong, W.W., Ooi, P.L., Lin, R.T.P., James, L. and Cutter, J., 2014.
Influenza-associated hospitalizations, Singapore, 2004–2008 and 2010–2012. Emerging infectious
diseases, 20(10), p.1652.
Ang, L.W., Lim, C., Lee, V.J.M., Ma, S., Tiong, W.W., Ooi, P.L., Lin, R.T.P., James, L. and Cutter, J., 2014.
Influenza-associated hospitalizations, Singapore, 2004–2008 and 2010–2012. Emerging infectious
diseases, 20(10), p.1652.

observational

1 year

otherwise healthy
ILI children

476

number hospitalized
out of 476

6 months-10
yrs

0.019

Taylor, S., Lopez, P., Weckx, L., Borja-Tabora, C., Ulloa-Gutierrez, R., Lazcano-Ponce, E., Kerdpanich,
A., Weber, M.A.R., de Los Santos, A.M., Tinoco, J.C. and Safadi, M.A.P., 2017. Respiratory viruses and
influenza-like illness: epidemiology and outcomes in children aged 6 months to 10 years in a multicountry population sample. Journal of Infection, 74(1), pp.29-41.

observational

2009-2013

out of all
respiratory

4378
annually

retrospective

1979-2001

all registered
deaths in Brazil

19 million

retrospective

1997-2007

all U.S.

observational

2018

hospitalized ILI
patients

observational

1 season

children

number hospitalized
out of 1,000

<5

0.0006

<5

0.0012

seasonal

PCR, culture,
DFA, RIDT

all

0.000030.0018

0.00092

case fatality rate

retrospective

1990-2008

per person-year
seasonal
influenza

Brazil govt. data

seasonal
influenza
seasonal
influenza
seasonal
influenza

New Zealand

deaths per 100,000
persons per year

0.00023

all

0.003

all

0.07

all

0.0827

all

0.000106

Cohen, C., Walaza, S., Treurnicht, F.K., McMorrow, M., Madhi, S.A., McAnerney, J.M. and Tempia, S.,
2017. In-and out-of-hospital mortality associated with seasonal and pandemic influenza and respiratory
syncytial virus in South Africa, 2009–2013. Clinical Infectious Diseases, 66(1), pp.95-103.
Alonso, W.J., Viboud, C., Simonsen, L., Hirano, E.W., Daufenbach, L.Z. and Miller, M.A., 2007.
Seasonality of influenza in Brazil: a traveling wave from the Amazon to the subtropics. American journal
of epidemiology, 165(12), pp.1434-1442.
Quandelacy, T.M., Viboud, C., Charu, V., Lipsitch, M. and Goldstein, E., 2013. Age-and sex-related risk
factors for influenza-associated mortality in the United States between 1997–2007. American journal of
epidemiology, 179(2), pp.156-167.
Mendez-Dominguez, N.I., Bobadilla-Rosado, L.O., Fajardo-Ruiz, L.S., Camara-Salazar, A. and GomezCarro, S., 2019. Influenza in Yucatan in 2018: Chronology, characteristics and outcomes of ambulatory
and hospitalized patients. Brazilian Journal of Infectious Diseases, 23(5), pp.358-362.
Kessaram, T., Stanley, J. and Baker, M.G., 2015. Estimating influenza-associated mortality in New
Zealand from 1990 to 2008. Influenza and other respiratory viruses, 9(1), pp.14-19.

R0
from clinical
data

Flu

estimated

FluA(H1N1)

estimated

FluA(H1N1)

1.73

1.06-1.69

1.35

3.4
Rp = transmissibility at
beginning of epidemic
in partially immune
population

estimated

1972-1997

USA, France,
Australia

seasonal

estimated

1996-2006

Brazil

seasonal

1.03

seasonal

1.28

estimated
(review)

24 studies

1.3

Wallinga, J. and Lipsitch, M., 2006. How generation intervals shape the relationship between growth
rates and reproductive numbers. Proceedings of the Royal Society B: Biological Sciences, 274(1609),
pp.599-604.
de Blasio, B.F., Iversen, B.G. and Tomba, G.S., 2012. Effect of vaccines and antivirals during the major
2009 A (H1N1) pandemic wave in Norway–and the influence of vaccination timing. PLoS One, 7(1),
p.e30018.
Sonthichai, C., Iamsirithaworn, S., Cummings, D.A.T., Shokekird, P., Niramitsantipong, A., Khumket, S.,
Chittaganpitch, M. and Lessler, J., 2011. Effectiveness of non-pharmaceutical interventions in
controlling an influenza A outbreak in a school, Thailand, November 2007. Outbreak, surveillance and
investigation reports, 4(2), pp.6-11.

Chowell, G.M.A.M., Miller, M.A. and Viboud, C., 2008. Seasonal influenza in the United States, France,
and Australia: transmission and prospects for control. Epidemiology & Infection, 136(6), pp.852-864.
Chowell, G., Viboud, C., Simonsen, L., Miller, M. and Alonso, W.J., 2010. The reproduction number of
seasonal influenza epidemics in Brazil, 1996–2006. Proceedings of the Royal Society B: Biological
Sciences, 277(1689), pp.1857-1866.
Biggerstaff, M., Cauchemez, S., Reed, C., Gambhir, M. and Finelli, L., 2014. Estimates of the
reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the
literature. BMC infectious diseases, 14(1), p.480.

RSV parameters: incubation period, infectious period, hospitalization period, hospitalization rate, case fatality rate, R0
parameter
incubation period

type of study

study time

population

systematic review

sample size strain

definition of parameter

notes

patient age range

range and
central tendency

review article

experimental

30 days

healthy adults

20

RSV

experimental

10 days

adult males

41

RSV

experimental

10 days

healthy adults

22

RSV

experimental

5 days

adults

36

RSV

review

before 2004

literature

NA

observational

1975-1995

211

observational

<= 1976

healthy adults
hospitalized
infants RSV

inoculation to peak
symptoms

3-7 days

mean

5 days

adult

4-7 days, median
5.9
5.5 days

adult

3-7 days

4 days

3-8 days

3 days

4-5 days

5 days

4-5 days

4.5 days

** 3-8 days is
length of time
inoculation to presence of virus was present
virus
after inoculation 21-50 yrs
inoculation to peak
symptoms
adult

citation

Spencer et al. ILI Review page 22

REVIEW: Lessler, J., Reich, N.G., Brookmeyer, R., Perl, T.M., Nelson, K.E. and Cummings, D.A., 2009.
Incubation periods of acute respiratory viral infections: a systematic review. The Lancet infectious diseases,
9(5), pp.291-300.
Zaas, A.K., Chen, M., Varkey, J., Veldman, T., Hero III, A.O., Lucas, J., Huang, Y., Turner, R., Gilbert, A.,
Lambkin-Williams, R. and Øien, N.C., 2009. Gene expression signatures diagnose influenza and other
symptomatic respiratory viral infections in humans. Cell host & microbe, 6(3), pp.207-217.
Johnson KM, Chanock RM, Rifkind D, Dravetz HM, Knight V. 1961. Respiratory syncytial virus infection in
adult volunteers. J.A.M.A. 176:663-677, 1961.

Pringle, C.R., Filipiuk, A.H., Robinson, B.S., Watt, P.J., Higgins, P. and Tyrrell, D.A.J., 1993. Immunogenicity
and pathogenicity of a triple temperature-sensitive modified respiratory syncytial virus in adult volunteers.
Vaccine, 11(4), pp.473-478.
Tyrell, D.A.J., Cohen, S. and Schilarb, J.E., 1993. Signs and symptoms in common colds. Epidemiology &
Infection, 111(1), pp.143-156.
REVIEW: Wat, D., 2004. The common cold: a review of the literature. European Journal of Internal Medicine,
15(2), pp.79-88.

infectious period
NA

NA (source: CDC) NA

NA

mean duration of illness
duration of RSV viral
shedding
mean duration of
contagious period

experimental

1 year

otherwise
healthy ILI
children

235

mean duration of ILI
episode

observational

1993-1995

children <= 4

10767

number of days from
admittance to discharge

observational

2001-2003

observational

1980-1996

hosp. respiratory 413
hosp.
bronchiolitis
1648281

median duration of
hospital stay in days
median length of hospital
stay

1 year

otherwise
healthy ILI
children

median duration of
hospitalization

observational

2003-2006

children in Hong
Kong
hospitalized for
acute respiratory
infection

observational

2009-2011

children < 5

23

infants

1- 21 days

6.7 days

Hall, C.B., Long, C.E. and Schnabel, K.C., 2001. Respiratory syncytial virus infections in previously healthy
working adults. Clinical infectious diseases, 33(6), pp.792-796.
Weber, A., Weber, M. and Milligan, P., 2001. Modeling epidemics caused by respiratory syncytial virus (RSV).
Mathematical biosciences, 172(2), pp.95-113.

all

3-8 days

5.5 days

CDC, "RSV Transmission," https://www.cdc.gov/rsv/about/transmission.html

6 months-10
yrs

9.2 days

Taylor, S., Lopez, P., Weckx, L., Borja-Tabora, C., Ulloa-Gutierrez, R., Lazcano-Ponce, E., Kerdpanich, A.,
Weber, M.A.R., de Los Santos, A.M., Tinoco, J.C. and Safadi, M.A.P., 2017. Respiratory viruses and influenzalike illness: epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population
sample. Journal of Infection, 74(1), pp.29-41.

<= 4 yrs

4.9 days

adult

9.5 days

hospitalization

observational

NA

235

50

NA

all

6-17.5 days

9.5 days

< 5 yrs

2-5 days

3 days

6 months-10
yrs

mean duration of
hospitalization

< 18 years

median length of hospital
stay

<5

6 days

3-5 days

Howard, T.S., Hoffman, L.H., Stang, P.E. and Simoes, E.A., 2000. Respiratory syncytial virus pneumonia in
the hospital setting: length of stay, charges, and mortality. The Journal of pediatrics, 137(2), pp.227-232.
Morrow, B.M., Hatherill, M., Smuts, H.E., Yeats, J., Pitcher, R. and Argent, A.C., 2006. Clinical course of
hospitalised children infected with human metapneumovirus and respiratory syncytial virus. Journal of
paediatrics and child health, 42(4), pp.174-178.
Shay, D.K., Holman, R.C., Newman, R.D., Liu, L.L., Stout, J.W. and Anderson, L.J., 1999. Bronchiolitisassociated hospitalizations among US children, 1980-1996. Jama, 282(15), pp.1440-1446.
Taylor, S., Lopez, P., Weckx, L., Borja-Tabora, C., Ulloa-Gutierrez, R., Lazcano-Ponce, E., Kerdpanich, A.,
Weber, M.A.R., de Los Santos, A.M., Tinoco, J.C. and Safadi, M.A.P., 2017. Respiratory viruses and influenzalike illness: epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population
sample. Journal of Infection, 74(1), pp.29-41.

Chiu, S.S., Chan, K.H., Chen, H., Young, B.W., Lim, W., Wong, W.H.S. and Peiris, J.M., 2010. Virologically
confirmed population-based burden of hospitalization caused by respiratory syncytial virus, adenovirus, and
parainfluenza viruses in children in Hong Kong. The Pediatric infectious disease journal, 29(12), pp.10884.04 days 1092.
Broor, S., Dawood, F.S., Pandey, B.G., Saha, S., Gupta, V., Krishnan, A., Rai, S., Singh, P., Erdman, D. and
Lal, R.B., 2014. Rates of respiratory virus-associated hospitalization in children aged< 5 years in rural
4 days
northern India. Journal of Infection, 68(3), pp.281-289.

hospitalization

2011-2012

adults with
cardiopulmonary
disease or
congestive heart
failure
445

observational

1996-2000

3 HMO
databases

observational

2000-2001

children ARI

observational

592

NA

proportion hospitalized
during study

*excluded from
plot. study pop
has advanced
pulmonary
disease or
congestive heart
failure.
>50

0.29

proportion hospitalized
per season

all

0.062

NA

proportion hospitalized
during study

<5

0.0035

<5

0.0035

<2

0.02

observational

2009-2011

children < 5

245

NA

proportion hospitalized
during study

observational

1989-2000

children < 2

4618

NA

proportion hospitalized
per year during study

Falsey, A.R., Walsh, E.E., Esser, M.T., Shoemaker, K., Yu, L. and Griffin, M.P., 2019. Respiratory syncytial
virus–associated illness in adults with advanced chronic obstructive pulmonary disease and/or congestive
heart failure. Journal of medical virology, 91(1), pp.65-71.
Mullooly, J.P., Bridges, C.B., Thompson, W.W., Chen, J., Weintraub, E., Jackson, L.A., Black, S., Shay, D.K.
and Vaccine Safety Datalink Adult Working Group, 2007. Influenza-and RSV-associated hospitalizations
among adults. Vaccine, 25(5), pp.846-855.
Iwane, M.K., Edwards, K.M., Szilagyi, P.G., Walker, F.J., Griffin, M.R., Weinberg, G.A., Coulen, C., Poehling,
K.A., Shone, L.P., Balter, S. and Hall, C.B., 2004. Population-based surveillance for hospitalizations
associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children.
Pediatrics, 113(6), pp.1758-1764.
Broor, S., Dawood, F.S., Pandey, B.G., Saha, S., Gupta, V., Krishnan, A., Rai, S., Singh, P., Erdman, D. and
Lal, R.B., 2014. Rates of respiratory virus-associated hospitalization in children aged< 5 years in rural
northern India. Journal of Infection, 68(3), pp.281-289.
Avendano, L.F., Palomino, M.A. and Larranaga, C., 2003. Surveillance for respiratory syncytial virus in infants
hospitalized for acute lower respiratory infection in Chile (1989 to 2000). Journal of clinical microbiology,
41(10), pp.4879-4882.

observational

1 year

observational

<= 1976

otherwise
healthy ILI
children
hospitalized
infants RSV

235

number hospitalized out
of 235

6 months-10
yrs

0.021

23

hospitalization proportion

infants

0.016

Taylor, S., Lopez, P., Weckx, L., Borja-Tabora, C., Ulloa-Gutierrez, R., Lazcano-Ponce, E., Kerdpanich, A.,
Weber, M.A.R., de Los Santos, A.M., Tinoco,
J.C. andetSafadi,
2017. Respiratory
viruses and influenzaSpencer
al. M.A.P.,
ILI Review
page 23
like illness: epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population
sample. Journal of Infection, 74(1), pp.29-41.
Weber, A., Weber, M. and Milligan, P., 2001. Modeling epidemics caused by respiratory syncytial virus (RSV).
Mathematical biosciences, 172(2), pp.95-113.

case fatality rate

review

1966-2009
1993-1995

children
hospitalized
children

36 studies

observational

10767

nationally weighted #
deaths/# cases

observational

2009-2013

all respiratory
illness

4378
annually

deaths per person-year

all

0.00031

observational

2001-2003

hosp. respiratory 413

deaths during study

< 5 yrs

0.0015

observational

2000

hosp. acute
bronchiolotis

deaths during study

< 1 yr

0.007

observational
review

1989-2000
before 2013

"fatality rate"
"mortality"

< 2 yrs

636

hosp. children <
2
4618

<= 18 yrs

0.165
0.004 - 0.0075

0.0575

.08-.1

0.001
0.09

1.2-2.1

1.65

REVIEW: Welliver Sr, R.C., Checchia, P.A., Bauman, J.H., Fernandes, A.W., Mahadevia, P.J. and Hall, C.B.,
2010. Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy
children. Current medical research and opinion, 26(9), pp.2175-2181.
Howard, T.S., Hoffman, L.H., Stang, P.E. and Simoes, E.A., 2000. Respiratory syncytial virus pneumonia in
the hospital setting: length of stay, charges, and mortality. The Journal of pediatrics, 137(2), pp.227-232.
Cohen, C., Walaza, S., Treurnicht, F.K., McMorrow, M., Madhi, S.A., McAnerney, J.M. and Tempia, S., 2017. Inand out-of-hospital mortality associated with seasonal and pandemic influenza and respiratory syncytial virus
in South Africa, 2009–2013. Clinical Infectious Diseases, 66(1), pp.95-103.
Morrow, B.M., Hatherill, M., Smuts, H.E., Yeats, J., Pitcher, R. and Argent, A.C., 2006. Clinical course of
hospitalised children infected with human metapneumovirus and respiratory syncytial virus. Journal of
paediatrics and child health, 42(4), pp.174-178.
Tsolia, M.N., Kafetzis, D., Danelatou, K., Astra, H., Kallergi, K., Spyridis, P. and Karpathios, T.E., 2003.
Epidemiology of respiratory syncytial virus bronchiolitis in hospitalized infants in Greece. European journal of
epidemiology, 18(1), pp.55-61.
Avendano, L.F., Palomino, M.A. and Larranaga, C., 2003. Surveillance for respiratory syncytial virus in infants
hospitalized for acute lower respiratory infection in Chile (1989 to 2000). Journal of clinical microbiology,
41(10), pp.4879-4882.
Lee, N., Qureshi, S.T., Other viral pneumonias. Crit Care Clin 29 (2013) 1045–1068

R0
estimated
estimated

estimated

3

2003-2009

estimated

2.26-8.9

4.6

1.2-2.1

1.65

8.9-9.1

9

estimated

1989-2009

estimated

2018

R0 at peak timing

2.82

estimated

2012-2017

average R0

1.6

Weber, A., Weber, M. and Milligan, P., 2001. Modeling epidemics caused by respiratory syncytial virus (RSV).
Mathematical biosciences, 172(2), pp.95-113.
Reis J., Shaman, J., 2016. RetrospectiveParameterEstimationand Forecastof RespiratorySyncytialVirusin the
UnitedStates.PLoSComputBiol 12(10):e1005133.doi:10.1371/journal.pcbi.1005133
Velasco-Hernández, J.X., Núñez-López, M., Comas-García, A., Cherpitel, D.E.N. and Ocampo, M.C., 2015.
Superinfection between influenza and RSV alternating patterns in San Luis potosí state, México. PloS one,
10(3), p.e0115674.
Duvvuri, V.R., Granados, A., Rosenfeld, P., Bahl, J., Eshaghi, A. and Gubbay, J.B., 2015. Genetic diversity
and evolutionary insights of respiratory syncytial virus A ON1 genotype: global and local transmission
dynamics. Scientific reports, 5, p.14268.
Pitzer, V.E., Viboud, C., Alonso, W.J., Wilcox, T., Metcalf, C.J., Steiner, C.A., Haynes, A.K. and Grenfell, B.T.,
2015. Environmental drivers of the spatiotemporal dynamics of respiratory syncytial virus in the United States.
PLoS pathogens, 11(1), p.e1004591.
Reis, J. and Shaman, J., 2018. Simulation of four respiratory viruses and inference of epidemiological
parameters. Infectious Disease Modelling, 3, pp.23-34.
Levy, N., Iv, M. and Yom-Tov, E., 2018. Modeling influenza-like illnesses through composite compartmental
models. Physica A: Statistical Mechanics and its Applications, 494, pp.288-293.

ADENOVIRUS parameters: incubation period, infectious period, hospitalization period, reduction of transmission in hospital, hospitalization rate, case fatality rate, R0
NOTE: adenovirus in the elderly produces keratoconjunctivitis, not a respiratory infection
parameter
incubation period

type of study

study time
2001-2002

population

systematic review

sample size strain
102

definition of

July to Sept
1996

experimental
textbook chapter

1945
NA

736

adult males

reference chapter NA
review

before 2004

textbook chapter

NA

observational

2001-2002

observational

1 year

5
NA

patient age
elderly (noso)

range and
central tendency all

review

anecdotal re
adenovirus

notes
* excluded from

observationa no definition, no
l
citation

ARD

NA

range
1-30 days

mean
15.5 days

4-8 days

6 days

federal service
training academy 6-9 days

7.5 days

inoculation to onset of ARD assumed to
symptoms
be adenovirus
adult
no defnition

5-6 days
4-12 days

5.5 days
8 days

no definition

2-4 days

3 days

4-14 days

9 days

2-14 days

8 days

17 days max

9 days

literature
in textbook

Spencer et al. ILI Review page 24

citation
Sendra-Gutiérrez, J.M., Martín-Rios, D., Casas, I., Sáez, P., Tovar, A. and Moreno, C., 2004. AN OUTBREAK OF
Lessler, J., Reich, N.G., Brookmeyer, R., Perl, T.M., Nelson, K.E. and Cummings, D.A., 2009. Incubation periods
of acute respiratory viral infections: a systematic review. The Lancet infectious diseases, 9(5), pp.291-300.
Feikin, D.R., Moroney, J.F., Talkington, D.F., Thacker, W.L., Code, J.E., Schwartz, L.A., Erdman, D.D., Butler, J.C.
and Cetron, M.S., 1999. An outbreak of acute respiratory disease caused by Mycoplasma pneumoniae and
adenovirus at a federal service training academy: new implications from an old scenario. Clinical infectious
diseases, pp.1545-1550.
Commission on Acute Respiratory Diseases, 1947. Experimental transmission of minor respiratory illness to
human volunteers by filter-passing agents. I. Demonstration of two types of illness characterized by long and
short incubation periods and different clinical features. Journal of Clinical Investigation, 26(5), pp.957-973.
Berger, S., 2010. Infectious Diseases of Bhutan 2010 edition. " O'Reilly Media, Inc.".
Tanz, R.R. "Sore Throat", Kliegman, R.M., Lye, P.S., Bordini, B.J., Toth, H. and Basel, D., 2017. Nelson Pediatric
Symptom-Based Diagnosis E-Book. Elsevier Health Sciences.
REVIEW: Wat, D., 2004. The common cold: a review of the literature. European Journal of Internal Medicine,
15(2), pp.79-88.
Robinson, C., & Echavarria, M. (2007). Adenoviruses. In P. R. Murray, E. J. Baron, J. Jorgensen, M. Pfaller & M. L.
Landry (Eds.), Manual of Clinical Microbiology (9th ed., pp. 1589) ASM Press.

infectious period

observational
textbook chapter
textbook chapter

102

otherwise healthy ILI
children

141

children positive for
adenovirus

74

elderly (noso)

seasonal

mean duration of ILI
episode

up to 1 week

4 days

3-6 weeks

31.5 days

4 days

Taylor, S., Lopez, P., Weckx, L., Borja-Tabora, C., Ulloa-Gutierrez, R., Lazcano-Ponce, E., Kerdpanich, A., Weber,
M.A.R., de Los Santos, A.M., Tinoco, J.C. and Safadi, M.A.P., 2017. Respiratory viruses and influenza-like illness:
epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample. Journal
of Infection, 74(1), pp.29-41.

6 months-10
years

9.2 days

10.6 days

NA

children

viral shedding period
after recovery
viral shedding period
following illness

1 year

otherwise healthy ILI
children

median duration of
hospitalization

2003-2006

children in Hong Kong
hospitalized for acute
respiratory infection

2 years

immunocompetent
children hospitalized
due to adenovirus

NA

Sendra-Gutiérrez, J.M., Martín-Rios, D., Casas, I., Sáez, P., Tovar, A. and Moreno, C., 2004. AN OUTBREAK OF
ADENOVIRUS TYPE 8. Euro Surveill, 9(3), pp.27-30.
Taylor, S., Lopez, P., Weckx, L., Borja-Tabora, C., Ulloa-Gutierrez, R., Lazcano-Ponce, E., Kerdpanich, A., Weber,
M.A.R., de Los Santos, A.M., Tinoco, J.C. and Safadi, M.A.P., 2017. Respiratory viruses and influenza-like illness:
epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample. Journal
of Infection, 74(1), pp.29-41.
Hong, J.Y., Lee, H.J., Piedra, P.A., Choi, E.H., Park, K.H., Koh, Y.Y. and Kim, W.S., 2001. Lower respiratory tract
infections due to adenovirus in hospitalized Korean children: epidemiology, clinical features, and prognosis.
Clinical infectious diseases, 32(10), pp.1423-1429.
Robinson, C., & Echavarria, M. (2007). Adenoviruses. In P. R. Murray, E. J. Baron, J. Jorgensen, M. Pfaller & M. L.
Landry (Eds.), Manual of Clinical Microbiology (9th ed., pp. 1589) ASM Press.
Robinson, C., & Echavarria, M. (2007). Adenoviruses. In P. R. Murray, E. J. Baron, J. Jorgensen, M. Pfaller & M. L.
Landry (Eds.), Manual of Clinical Microbiology (9th ed., pp. 1589) ASM Press.

adults

* excluded from
plot

hospitalization period

observational

observational

observational

141

seasonal

78

6 months-10
years

mean duration of
hospitalization

< 18 years

3.12 days

Chiu, S.S., Chan, K.H., Chen, H., Young, B.W., Lim, W., Wong, W.H.S. and Peiris, J.M., 2010. Virologically
confirmed population-based burden of hospitalization caused by respiratory syncytial virus, adenovirus, and
parainfluenza viruses in children in Hong Kong. The Pediatric infectious disease journal, 29(12), pp.1088-1092.

mean duration of
hospitalization

17 ± 10 months

7 days

Peled, N., Nakar, C., Huberman, H., Scherf, E., Samra, Z., Finkelstein, Y., Hoffer, V. and Garty, B.Z., 2004.
Adenovirus infection in hospitalized immunocompetent children. Clinical pediatrics, 43(3), pp.223-229.

hospitalization rate

observational

1957

observational

1 year

observational

1990-1998

0.418

18-59

0.667

percent hospitalized
due to adenovirus in 1
yr

military recruits

otherwise healthy ILI
children
children w/ lower
respiratory tract
infection

< 18

141

seasonal

percent hospitalized

0.1

6 months-10
years

percent of study
patients hospitalized

0.014

0.95

Galindo-Fraga, A., Ortiz-Hernández, A.A., Ramírez-Venegas, A., Vázquez, R.V., Moreno-Espinosa, S., LlamosasGallardo, B., Pérez-Patrigeon, S., Salinger, M., Freimanis, L., Huang, C.Y. and Gu, W., 2013. Clinical
characteristics and outcomes of influenza and other influenza-like illnesses in Mexico City. International Journal
of Infectious Diseases, 17(7), pp.e510-e517.
Galindo-Fraga, A., Ortiz-Hernández, A.A., Ramírez-Venegas, A., Vázquez, R.V., Moreno-Espinosa, S., LlamosasGallardo, B., Pérez-Patrigeon, S., Salinger, M., Freimanis, L., Huang, C.Y. and Gu, W., 2013. Clinical
characteristics and outcomes of influenza and other influenza-like illnesses in Mexico City. International Journal
of Infectious Diseases, 17(7), pp.e510-e517.
Hilleman, M.R., Gauld, R.L., BUTLEB, R., Stallones, R.A., Hedberg, C.L., Warfield, M.S. and Anderson, S.A.,
1957. Appraisal of occurrence of adenovirus-caused respiratory illness in military populations. American journal
of hygiene, 66(1), pp.29-41.
Taylor, S., Lopez, P., Weckx, L., Borja-Tabora, C., Ulloa-Gutierrez, R., Lazcano-Ponce, E., Kerdpanich, A., Weber,
M.A.R., de Los Santos, A.M., Tinoco, J.C. and Safadi, M.A.P., 2017. Respiratory viruses and influenza-like illness:
epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample. Journal
of Infection, 74(1), pp.29-41.
Hong, J.Y., Lee, H.J., Piedra, P.A., Choi, E.H., Park, K.H., Koh, Y.Y. and Kim, W.S., 2001. Lower respiratory tract
infections due to adenovirus in hospitalized Korean children: epidemiology, clinical features, and prognosis.
Clinical infectious diseases, 32(10), pp.1423-1429.

case fatality rate

observational
observational

adenovirus infected
children

observational

pediatric chronic care
residents

18-59
excluded from
plot: nosocomial young children

children

0.067
0.67

0.16

Galindo-Fraga, A., Ortiz-Hernández, A.A., Ramírez-Venegas, A., Vázquez, R.V., Moreno-Espinosa, S., LlamosasGallardo, B., Pérez-Patrigeon, S., Salinger, M., Freimanis, L., Huang, C.Y. and Gu, W., 2013. Clinical
characteristics and outcomes of influenza and other influenza-like illnesses in Mexico City. International Journal
of Infectious Diseases, 17(7), pp.e510-e517.
Wesley, A.G., Pather, M. and Tait, D., 1993. Nosocomial adenovirus infection in a paediatric respiratory unit.
Journal of Hospital Infection, 25(3), pp.183-190.
Gerber, S.I., Erdman, D.D., Pur, S.L., Diaz, P.S., Segreti, J., Kajon, A.E., Belkengren, R.P. and Jones, R.C., 2001.
Outbreak of adenovirus genome type 7d2 infection in a pediatric chronic-care facility and tertiary-care hospital.
Clinical infectious diseases, 32(5), pp.694-700.

observational

2013-2018

hospitalized infants
adult patients w/ acute
respiratory infection in
Korean military
hospitals

observational

1990-1998

children positive for
adenovirus

estimated

2018

simulated

observational

1995-1996

< 2 years

adults

74

0.166

Larrañaga, C., Martínez, J., Palomino, A., Peña, M. and Carrión, F., 2007. Molecular characterization of hospitalacquired adenovirus infantile respiratory infection in Chile using species-specific PCR assays. Journal of clinical
Spencer et al. ILI Review page 25
virology, 39(3), pp.175-181.

0.12

Ko, J.H., Woo, H.T., Oh, H.S., Moon, S.M., Choi, J.Y., Lim, J.U., Kim, D., Byun, J., Kwon, S.H., Kang, D. and Heo,
J.Y., 2019. Ongoing outbreak of human adenovirus-associated acute respiratory illness in the Republic of Korea
military, 2013 to 2018. Korean J Intern Med, 34(5), pp.1171-1171.
Hong, J.Y., Lee, H.J., Piedra, P.A., Choi, E.H., Park, K.H., Koh, Y.Y. and Kim, W.S., 2001. Lower respiratory tract
infections due to adenovirus in hospitalized Korean children: epidemiology, clinical features, and prognosis.
Clinical infectious diseases, 32(10), pp.1423-1429.

2.34

Reis, J. and Shaman, J., 2018. Simulation of four respiratory viruses and inference of epidemiological
parameters. Infectious Disease Modelling, 3, pp.23-34.

0.00075

R0

R0 at peak timing

HUMAN CORONAVIRUS parameters: incubation period, infectious period, onset of symptoms to hospitalization, hospitalization period, hospitalization proportion, case fatality, R0

SARS

incubation period

all

3.6-4.4 days

4 days

26

229E culture

2-4 days

3.3 days

229E culture

inoculation to onset
inoculation to peak
symptoms

18-50

34

adult

3-4 days

3.5 days

incubation period

all

2-4 days

3 days

Spencer et al. ILI Review page 26
citation
Lessler, J., Reich, N.G., Brookmeyer, R., Perl, T.M., Nelson, K.E. and Cummings, D.A., 2009. Incubation
periods of acute respiratory viral infections: a systematic review. The Lancet infectious diseases, 9(5),
pp.291-300.
Bradburne, A.F., Bynoe, M.L. and Tyrrell, D.A., 1967. Effects of a" new" human respiratory virus in
volunteers. British medical journal, 3(5568), p.767.
Tyrell, D.A.J., Cohen, S. and Schilarb, J.E., 1993. Signs and symptoms in common colds. Epidemiology
& Infection, 111(1), pp.143-156.
Wat, D., 2004. The common cold: a review of the literature. European Journal of Internal Medicine, 15(2),
pp.79-88.

3.5 days

Valtonen, M., Waris, M., Vuorinen, T., Eerola, E., Hakanen, A.J., Mjosund, K., Grönroos, W., Heinonen,
O.J. and Ruuskanen, O., 2019. Common cold in Team Finland during 2018 Winter Olympic Games
(PyeongChang): epidemiology, diagnosis including molecular point-of-care testing (POCT) and
treatment. British journal of sports medicine, 53(17), pp.1093-1098.

parameter

type of study

study time

population

sample size strain

incubation period

review

pre-2009

literature

experimental

1967
June 1986-July
1989

adults

experimental

adults

review

before 2004

literature

observational

winter 2018

Olympic athletes &
staff

observational

April 1-May 23,
1013

retrospective

2015

retrospective

2015

hospitalized
confirmed cased
(Korea)
confirmed cases
(Korea)

review

pre-May 2003

consensus document

review

2003-2004

literature

1 year

otherwise healthy ILI
children
103

112

definition of parameter

notes

229E,OC43,NL
63
incubation period

patient age

value range

mean

adult

23

MERS

incubation period

36

MERS

incubation period

134

MERS

incubation period

SARS

incubation period

all

SARS

incubation period

all

mean duration of ILI
episode

6 months-10
years

patients who
died
patients who
survived

all

1.9-14.7 days

5.2 days

all

5.2-7.9 days

6.4 days

all

6.3-7.8 days

7.1 days
10 days

4.0-5.3 days

4.7 days

Assiri, A., Al-Tawfiq, J.A., Al-Rabeeah, A.A., Al-Rabiah, F.A., Al-Hajjar, S., Al-Barrak, A., Flemban, H., AlNassir, W.N., Balkhy, H.H., Al-Hakeem, R.F. and Makhdoom, H.Q., 2013. Epidemiological, demographic,
and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from
Saudi Arabia: a descriptive study. The Lancet infectious diseases, 13(9), pp.752-761.
Virlogeux, V., Park, M., Wu, J.T. and Cowling, B.J., 2016. Association between severity of MERS-CoV
infection and incubation period. Emerging infectious diseases, 22(3), p.526.
Virlogeux, V., Park, M., Wu, J.T. and Cowling, B.J., 2016. Association between severity of MERS-CoV
infection and incubation period. Emerging infectious diseases, 22(3), p.526.
World Health Organization, 2003. Consensus document on the epidemiology of severe acute respiratory
syndrome (SARS) (No. WHO/CDS/CSR/GAR/2003.11). World Health Organization.
Anderson, R.M., Fraser, C., Ghani, A.C., Donnelly, C.A., Riley, S., Ferguson, N.M., Leung, G.M., Lam,
T.H. and Hedley, A.J., 2004. Epidemiology, transmission dynamics and control of SARS: the 2002–2003
epidemic. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences,
359(1447), pp.1091-1105.

infectious period

observational

observational

229E,OC43,NL
63
duration of illness

neonates w/ NL63

observational

Aug 2001-Aug
2002

children hospitalized
w/ HcoV-NL63

observational

winter 2018

Olympic athletes &
staff

review

2003-2004

literature

SARS

infectiousness

estimated

2002-2003

literature/model

SARS

mean infectious period

observational

April 1-May 23,
2013

confirmed MERSCoV

23

MERS

review

pre-2017

literature

NA

MERS

onset of symptoms to ICU
admission
onset of symptoms to
hospitalization

observational

2013

confirmed MERSCoV

17

MERS

onset of symptoms to
hospitalization

retrospective

2002-2003

1st 205 probable
cases

205

SARS

onset of symptoms to
isolation

observational

2014

hospitalized
confirmed

9

MERS

observational

observational

NL63

112

10.1 days

1-4 weeks

mean duration of fever

229E,OC43,NL
6
duration of illness

13.46 days

Taylor, S., Lopez, P., Weckx, L., Borja-Tabora, C., Ulloa-Gutierrez, R., Lazcano-Ponce, E., Kerdpanich,
A., Weber, M.A.R., de Los Santos, A.M., Tinoco, J.C. and Safadi, M.A.P., 2017. Respiratory viruses and
influenza-like illness: epidemiology and outcomes in children aged 6 months to 10 years in a multicountry population sample. Journal of Infection, 74(1), pp.29-41.
Kaiser, L., Regamey, N., Roiha, H., Deffernez, C. and Frey, U., 2005. Human coronavirus NL63
associated with lower respiratory tract symptoms in early life. The Pediatric infectious disease journal,
24(11), pp.1015-1017.

⩽18 years

1-5 days

2.6 days

adults

2-25 days

10.33 days

27-35 days

31 days

Chiu, S.S., Hung Chan, K., Wing Chu, K., Kwan, S.W., Guan, Y., Man Poon, L.L. and Peiris, J.S.M., 2005.
Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute
respiratory disease in Hong Kong, China. Clinical infectious diseases, 40(12), pp.1721-1729.
Valtonen, M., Waris, M., Vuorinen, T., Eerola, E., Hakanen, A.J., Mjosund, K., Grönroos, W., Heinonen,
O.J. and Ruuskanen, O., 2019. Common cold in Team Finland during 2018 Winter Olympic Games
(PyeongChang): epidemiology, diagnosis including molecular point-of-care testing (POCT) and
treatment. British journal of sports medicine, 53(17), pp.1093-1098.
Anderson, R.M., Fraser, C., Ghani, A.C., Donnelly, C.A., Riley, S., Ferguson, N.M., Leung, G.M., Lam,
T.H. and Hedley, A.J., 2004. Epidemiology, transmission dynamics and control of SARS: the 2002–2003
epidemic. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences,
359(1447), pp.1091-1105.

23.5 days

Chowell, G., Castillo-Chavez, C., Fenimore, P.W., Kribs-Zaleta, C.M., Arriola, L. and Hyman, J.M., 2004.
Model parameters and outbreak control for SARS. Emerging Infectious Diseases, 10(7), p.1258.

from Fig. 5

onset to

all

2-6 days

4 days

Assiri, A., Al-Tawfiq, J.A., Al-Rabeeah, A.A., Al-Rabiah, F.A., Al-Hajjar, S., Al-Barrak, A., Flemban, H., AlNassir, W.N., Balkhy, H.H., Al-Hakeem, R.F. and Makhdoom, H.Q., 2013. Epidemiological, demographic,
and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from
Saudi Arabia: a descriptive study. The Lancet infectious diseases, 13(9), pp.752-761.
Fehr, A.R., Channappanavar, R. and Perlman, S., 2017. Middle East respiratory syndrome: emergence
of a pathogenic human coronavirus. Annual review of medicine, 68, pp.387-399.
Al-Tawfiq, J.A., Hinedi, K., Ghandour, J., Khairalla, H., Musleh, S., Ujayli, A. and Memish, Z.A., 2014.
Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients. Clinical
Infectious Diseases, 59(2), pp.160-165.
Lipsitch, M., Cohen, T., Cooper, B., Robins, J.M., Ma, S., James, L., Gopalakrishna, G., Chew, S.K., Tan,
C.C., Samore, M.H. and Fisman, D., 2003. Transmission dynamics and control of severe acute
respiratory syndrome. Science, 300(5627), pp.1966-1970

onset to hospitalization

all

0-8 days

3 days

Corman, V.M., Albarrak, A.M., Omrani, A.S., Albarrak, M.M., Farah, M.E., Almasri, M., Muth, D., Sieberg,
A., Meyer, B., Assiri, A.M. and Binger, T., 2016. Viral shedding and antibody response in 37 patients with
Middle East respiratory syndrome coronavirus infection. Clinical Infectious Diseases, 62(4), pp.477-483.

1 year

otherwise healthy ILI
children
103

median duration of
hospitalization

6 months-10
years

1.5 days

Taylor, S., Lopez, P., Weckx, L., Borja-Tabora, C., Ulloa-Gutierrez, R., Lazcano-Ponce, E., Kerdpanich,
A., Weber, M.A.R., de Los Santos, A.M., Tinoco, J.C. and Safadi, M.A.P., 2017. Respiratory viruses and
influenza-like illness: epidemiology and outcomes in children aged 6 months to 10 years in a multicountry population sample. Journal of Infection, 74(1), pp.29-41.

Aug 2001-Aug
2002

children w/ HcoVNL63

mean duration of
hospitalization

2.46 days

Chiu, S.S., Hung Chan, K., Wing Chu, K., Kwan, S.W., Guan, Y., Man Poon, L.L. and Peiris, J.S.M., 2005.
Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute
respiratory disease in Hong Kong, China. Clinical infectious diseases, 40(12), pp.1721-1729.

all

median

1-10 days

5 days

all

4 days

all

3 days

hospitalization period

NL-63

⩽18 years

observational

2001-2003

children w/ HcoV-NL
hospitalized for acute
respiratory tract
infections
12

observational

2014

hospitalized
confirmed

1 year

otherwise healthy ILI
children
103

37

MERS

mean duration of
hospitalization

≤3 years

4.9 days

Boivin, G., Baz, M., Côté, S., Gilca, R., Deffrasnes, C., Leblanc, É., Bergeron, M.G., Déry, P. and De
Spencer et al. ILI Review page 27
Serres, G., 2005. Infections by human coronavirus-NL in hospitalized children. The Pediatric infectious
disease journal, 24(12), pp.1045-1048.

average time of
hospitalization

all

11 days

Corman, V.M., Albarrak, A.M., Omrani, A.S., Albarrak, M.M., Farah, M.E., Almasri, M., Muth, D., Sieberg,
A., Meyer, B., Assiri, A.M. and Binger, T., 2016. Viral shedding and antibody response in 37 patients with
Middle East respiratory syndrome coronavirus infection. Clinical Infectious Diseases, 62(4), pp.477-483.

percent hospitalized

6 months-10
years

0.019

percent hospitalized

1 month-100
years

0.21

percent hospitalized

all

0.52

Taylor, S., Lopez, P., Weckx, L., Borja-Tabora, C., Ulloa-Gutierrez, R., Lazcano-Ponce, E., Kerdpanich,
A., Weber, M.A.R., de Los Santos, A.M., Tinoco, J.C. and Safadi, M.A.P., 2017. Respiratory viruses and
influenza-like illness: epidemiology and outcomes in children aged 6 months to 10 years in a multicountry population sample. Journal of Infection, 74(1), pp.29-41.
Bastien, N., Anderson, K., Hart, L., Caeseele, P.V., Brandt, K., Milley, D., Hatchette III, T., Weiss, E.C. and
Li, Y., 2005. Human coronavirus NL63 infection in Canada. The Journal of infectious diseases, 191(4),
pp.503-506.
Reina, J., López-Causapé, C., Rojo-Molinero, E. and Rubio, R., 2014. Clinico-epidemiological
characteristics of acute respiratory infections by coronavirus OC43, NL63 and 229E. Revista Clínica
Española (English Edition), 214(9), pp.499-504.
Chiu, S.S., Hung Chan, K., Wing Chu, K., Kwan, S.W., Guan, Y., Man Poon, L.L. and Peiris, J.S.M., 2005.
Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute
respiratory disease in Hong Kong, China. Clinical infectious diseases, 40(12), pp.1721-1729.

hospitalization

observational

observational

Jan-Mar 2002

observational

observational

Aug 2001-Aug
2002

HcoV-NL63 positive
patients
coronavirus positive
patients w/ clinical
respiratory infection

19

seasonal

NL63

48

children w/ HcoVNL63

NL63

percent hospitalized

⩽18 years

0.0022

confirmed MERScoV cases

MERS

case fatality rate

all

0.33

MERS

case fatality rate

0.19

NL63

case fatality rate

0.053

case fatality rate
case fatality rate

all

MERS

case fatality rate

> 65 years

0

MERS

case fatality rate

all

0.344

MERS

R0

4.5

MERS

R0

8

SARS

R0

2.7

MERS

R0
R0

0.1351 or
5.3973
2.2-3.7

2.77
2.95

SARS

R0

2.2-3.6

3

SARS

R0

3

SARS

R0

2.7

case fatality
review

retrospective

2015

observational

Jan-Mar 2002

MERS-CoV South
Korea

186

observational

1995-2000

HcoV-NL63 positive
children
19
coronavirus positive
patients w/ clinical
respiratory infection 48
MERS-CoV
HcoV positive elderly
patients w/
underlying
conditions
5

retrospective

2002-2019

confirmed cases

observational
review

2494

6--16%

0
0.11

Ramadan, N. and Shaib, H. (2019) ‘Middle East respiratory syndrome coronavirus (MERS-CoV): A
review’, Germs, 9(1), pp. 35-42.
Chang, H.J., 2017. Estimation of basic reproduction number of the Middle East respiratory syndrome
coronavirus (MERS-CoV) during the outbreak in South Korea, 2015. Biomedical engineering online,
16(1), p.79
Bastien, N., Anderson, K., Hart, L., Caeseele, P.V., Brandt, K., Milley, D., Hatchette III, T., Weiss, E.C. and
Li, Y., 2005. Human coronavirus NL63 infection in Canada. The Journal of infectious diseases, 191(4),
pp.503-506.
Reina, J., López-Causapé, C., Rojo-Molinero, E. and Rubio, R., 2014. Clinico-epidemiological
characteristics of acute respiratory infections by coronavirus OC43, NL63 and 229E. Revista Clínica
Española (English Edition), 214(9), pp.499-504.
Lee, N., Qureshi, S.T., Other viral pneumonias. Crit Care Clin 29 (2013) 1045–1068

Falsey, A.R., Walsh, E.E. and Hayden, F.G., 2002. Rhinovirus and coronavirus infection-associated
hospitalizations among older adults. The Journal of infectious diseases, 185(9), pp.1338-1341.
WHO, "MERS Situation Update, November 2019," accessed on January 30, 2020.
http://applications.emro.who.int/docs/EMRPUB-CSR-241-2019-EN.pdf?ua=1&ua=1&ua=1

R0
MERS-CoV Saudi
Arabia

estimated

estimated

2015

MERS-CoV South
Korea

186

SARS-CoV Hong
Kong

estimated

estimated
estimated

2015

estimated

2002-2003

MERS-CoV South
Korea
hCoV
SARSSingapore/Hong
Kong

review

2002-2003

SARS (literature)

retrospective/estima
ted
2002-2003

SARS

205

1512

Majumder, M.S., Rivers, C., Lofgren, E. and Fisman, D., 2014. Estimation of MERS-coronavirus
reproductive number and case fatality rate for the spring 2014 Saudi Arabia outbreak: insights from
publicly available data. PLoS currents, 6.
Chang, H.J., 2017. Estimation of basic reproduction number of the Middle East respiratory syndrome
coronavirus (MERS-CoV) during the outbreak in South Korea, 2015. Biomedical engineering online,
16(1), p.79
Leung, G.M., Chung, P.H., Tsang, T., Lim, W., Chan, S.K., Chau, P., Donnelly, C.A., Ghani, A.C., Fraser,
C., Riley, S. and Ferguson, N.M., 2004. SARS-CoV antibody prevalence in all Hong Kong patient
contacts. Emerging infectious diseases, 10(9), p.1653.
Kim, Y., Lee, S., Chu, C., Choe, S., Hong, S. and Shin, Y., 2016. The characteristics of Middle Eastern
respiratory syndrome coronavirus transmission dynamics in South Korea. Osong public health and
research perspectives, 7(1), pp.49-55.
Lee, N., Qureshi, S.T., Other viral pneumonias. Crit Care Clin 29 (2013) 1045–1068
Lipsitch, M., Cohen, T., Cooper, B., Robins, J.M., Ma, S., James, L., Gopalakrishna, G., Chew, S.K., Tan,
C.C., Samore, M.H. and Fisman, D., 2003. Transmission dynamics and control of severe acute
respiratory syndrome. Science, 300(5627), pp.1966-1970
Bauch, C.T., Lloyd-Smith, J.O., Coffee, M.P. and Galvani, A.P., 2005. Dynamically modeling SARS and
other newly emerging respiratory illnesses: past, present, and future. Epidemiology, pp.791-801.
Riley, S., Fraser, C., Donnelly, C.A., Ghani, A.C., Abu-Raddad, L.J., Hedley, A.J., Leung, G.M., Ho, L.M.,
Lam, T.H., Thach, T.Q. and Chau, P., 2003. Transmission dynamics of the etiological agent of SARS in
Hong Kong: impact of public health interventions. Science, 300(5627), pp.1961-1966.

RHINOVIRUS parameters: incubation period, infectious period, hospitalization period, hospitalization proportion, case fatality, R0
parameter
incubation period

type of study

study time

population

sample size

systematic review before 2009

literature

8 exp/obs
studies

review

before 2011

literature

experimental

30 days

male prisoners

strain

13

RV type 15

30 days

asthmatic subjects

10

experimental

30 days

asthmatic subjects

10

RV type 16

experimental

5 days

healthy adults

21

RV type 23

experimental

5 days

healthy adults

27

T-39 and HH

healthy adults

patient age range value range

range and central tendency

experimental

5 days

notes

mean

2-4 days

2 days

adult

2-4 days

3 days

18 to 55

1-5.5 days

2.5 days

18 to 55

1-1 days

1 days

18 to 45

2-2 days

2 days

adult

2-3 days

2.5 days

adult

0.42-0.67 days 0.55 days

adult

2-4 days

3 days

adult

2-3 days

2.5 days

2-7 days

4.5 days

citation network

RV type 16
+allergen

experimental

definition of parameter

18

T-39

experimental

30 days

healthy adults

20

HRV

experimental

5 days

adults

193

RV9 and RV14

review

before 2004

literature

inoculation to appearance of
symptoms
inoculation to appearance of
symptoms
inoculation to appearance of
symptoms
inoculation to appearance of
symptoms
inoculation to peak
symptoms
inoculation to appearance of
symptoms

earliest possible
sore/scratchy throat

incoculation to peak
symptoms
inoculation to peak
symptoms

citation

Spencer et al. ILI Review page 28

REVIEW: Lessler, J., Reich, N.G., Brookmeyer, R., Perl, T.M., Nelson, K.E. and Cummings, D.A., 2009. Incubation
periods of acute respiratory viral infections: a systematic review. The Lancet infectious diseases, 9(5), pp.291-300.
REVIEW: Reich NG, Perl TM, Cummings DAT, Lessler J, 2011. Visualizing clinical evidence: citation networks for the
incubation periods of respiratory viral infections. PLoS One 6(4), 1-6.
Douglas, RG, Rossen, RD, Butler, WT, Couch, RB, 1967. Rhinovirus neutralizing antibody in tears, parotid saliva, nasal
secretions and serum. The Journal of Immunology, 99(2), 297-303.
Avila, PC, Abisheganaden, JA, Wong, H, Liu, J, Yagi, S, Schnurr, DS, Kishiyama, JL, Boushey, HA, 2009. Effects of
allergic inflammation of the nasal mucosa on the severity of rhinovirus 16 cold. Journal of Allergy and Clinical
Immunology, 105(5), 923-931.
Avila et al (above).
Drake CL, Roehrs TA, Royer H, Koshorek G, Turner RB, Roth T, 2000. Effects of an experimentally induced rhinovirus
cold on sleep, performance, and daytime alertness. Physiology and Behavior: 71(1-2), 75-81.
Naclerio RM, Proud D, Lichtenstein LM, Kagey-Sobotka A, Hendley JO,, Sorrentino J, Gwaltney JM, 1987. Kinins are
generated during experimental rhinovirus colds. Th Journal of Infectious Diseases: 157(1), 133-142.
Harris JM, Gwaltney JM, 1996. Incubation periods of experimental rhinovirus infection and illness. Clinical Infectious
Diseases: 23, 1287-90.
Zaas, A.K., Chen, M., Varkey, J., Veldman, T., Hero III, A.O., Lucas, J., Huang, Y., Turner, R., Gilbert, A., LambkinWilliams, R. and Øien, N.C., 2009. Gene expression signatures diagnose influenza and other symptomatic respiratory
viral infections in humans. Cell host & microbe, 6(3), pp.207-217.
Tyrell, D.A.J., Cohen, S. and Schilarb, J.E., 1993. Signs and symptoms in common colds. Epidemiology & Infection,
111(1), pp.143-156.
REVIEW: Wat, D., 2004. The common cold: a review of the literature. European Journal of Internal Medicine, 15(2),
pp.79-88.

infectious period

observational

1 year

observational

winters 1992-3
and 1993-4

observational

Sept-Oct 1994

experimental

otherwise healthy ILI
children
elderly patients w/
single rhinovirus
infection
HSV culture-positive
adults
healthy adult males

6 months-10 days

9.6 days

elderly

16 days

adult

11 days

adult

10 days

average length of symptoms

all

7 days

Taylor, S., Lopez, P., Weckx, L., Borja-Tabora, C., Ulloa-Gutierrez, R., Lazcano-Ponce, E., Kerdpanich, A., Weber,
M.A.R., de Los Santos, A.M., Tinoco, J.C. and Safadi, M.A.P., 2017. Respiratory viruses and influenza-like illness:
epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample. Journal of
Infection, 74(1), pp.29-41.
Nicholson, K.G., Kent, J., Hammersley, V. and Cancio, E., 1996. Risk factors for lower respiratory complications of
rhinovirus infections in elderly people living in the community: prospective cohort study. Bmj, 313(7065), pp.11191123.
Arruda, E., Pitkäranta, A.N.N.E., Witek, T.J., Doyle, C.A. and Hayden, F.G., 1997. Frequency and natural history of
rhinovirus infections in adults during autumn. Journal of clinical microbiology, 35(11), pp.2864-2868.
Douglas Jr, R.G., Cate, T.R., Gerone, P.J. and Couch, R.B., 1966. Quantitative rhinovirus shedding patterns in
volunteers. American Review of Respiratory Disease, 94(2), pp.159-167.
Landry, Marie Louise. Rhinoviruses . In P. R. Murray, E. J. Baron, J. Jorgensen, M. Pfaller & M. L. Landry (Eds.), Manual
of Clinical Microbiology (9th ed., pp. 1405) ASM Press.

6 months-10
years

1.5 days

Taylor, S., Lopez, P., Weckx, L., Borja-Tabora, C., Ulloa-Gutierrez, R., Lazcano-Ponce, E., Kerdpanich, A., Weber,
M.A.R., de Los Santos, A.M., Tinoco, J.C. and Safadi, M.A.P., 2017. Respiratory viruses and influenza-like illness:
epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample. Journal of
Infection, 74(1), pp.29-41.

198

median duration of
hospitalization
diff. btw. length of hospital
stay for HRV positive vs. no
respiratory virus

children

0.4 days

332

median length of stay

< 5 years

1.67 days

percent hospitalized

6 months-10
years

0.024

rhinovirus associated
hospitalization per year

adult

0.003

percent hospitalized out of
infants with HRV

infant

0.0093

percent of patients who died

elderly

0.0104

percent of patients who died

elderly

0.125

Nicholson, K.G., Kent, J., Hammersley, V. and Cancio, E., 1996. Risk factors for lower respiratory complications of
rhinovirus infections in elderly people living in the community: prospective cohort study. Bmj, 313(7065), pp.11191123.
Fica, A., Dabanch, J., Andrade, W., Bustos, P., Carvajal, I., Ceroni, C., Triantaﬁlo, V., Castro, M. and Fasce, R., 2015.
Clinical relevance of rhinovirus infections among adult hospitalized patients. Brazilian Journal of Infectious Diseases,
19(2), pp.118-124.

percent of patients who died

> 65 years

0

Falsey, A.R., Walsh, E.E. and Hayden, F.G., 2002. Rhinovirus and coronavirus infection-associated hospitalizations
among older adults. The Journal of infectious diseases, 185(9), pp.1338-1341.

986

mean duration of ILI episode

96

median duration of illness
median duration of cold
episode

32

textbook chapter

inoculation w/ NIH
1734
viral shedding period

*excluded from plot

hospitalization period

observational

1 year

retrospective

Jan 2014-Apr
2015

observational

2003-2005

otherwise healthy ILI
children

hospitalized children
RSV positive children
hospitalized for acute
respiratory illness

986

Tam, P.Y.I., Zhang, L. and Cohen, Z., 2018. Clinical characteristics and outcomes of human rhinovirus positivity in
hospitalized children. Annals of thoracic medicine, 13(4), p.230.
Iwane, M.K., Prill, M.M., Lu, X., Miller, E.K., Edwards, K.M., Hall, C.B., Griffin, M.R., Staat, M.A., Anderson, L.J., Williams,
J.V. and Weinberg, G.A., 2011. Human rhinovirus species associated with hospitalizations for acute respiratory illness
in young US children. Journal of Infectious Diseases, 204(11), pp.1702-1710.

hospitalization proportion

observational

observational

observational

1 year

2008-2010

1998-2001

otherwise healthy ILI
children
US adults seen in
hospital, ED, or
outpatient clinic

986

ILI infants

Taylor, S., Lopez, P., Weckx, L., Borja-Tabora, C., Ulloa-Gutierrez, R., Lazcano-Ponce, E., Kerdpanich, A., Weber,
M.A.R., de Los Santos, A.M., Tinoco, J.C. and Safadi, M.A.P., 2017. Respiratory viruses and influenza-like illness:
epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample. Journal of
Infection, 74(1), pp.29-41.
Miller, E.K., Linder, J., Kraft, D., Johnson, M., Lu, P., Saville, B.R., Williams, J.V., Griffin, M.R. and Talbot, H.K., 2016.
Hospitalizations and outpatient visits for rhinovirus-associated acute respiratory illness in adults. Journal of Allergy and
Clinical Immunology, 137(3), pp.734-743.
Lee, W.M., Lemanske Jr, R.F., Evans, M.D., Vang, F., Pappas, T., Gangnon, R., Jackson, D.J. and Gern, J.E., 2012.
Human rhinovirus species and season of infection determine illness severity. American journal of respiratory and
critical care medicine, 186(9), pp.886-891.

case fatality proportion

observational

2012

observational

1995-2000

elderly patients w/
single RSV infection
96
elderly patients w/ RSVassociated respiratory
infection
32
RSV positive elderly
patients w/ underlying
conditions
4

estimated

2018

simulated

R0 at peak timing

2.6

estimated
estimated from
non-invasive
observation

2012-2017

simulated

average R0 value

1.2

wild chimpanzees

average R0

1.83

observational

R0
Reis, J. and Shaman, J., 2018. Simulation of four respiratory viruses and inference of epidemiological parameters.
Infectious Disease Modelling, 3, pp.23-34.
Levy, N., Iv, M. and Yom-Tov, E., 2018. Modeling influenza-like illnesses through composite compartmental models.
Physica A: Statistical Mechanics and its Applications, 494, pp.288-293.
Scully, E.J., Basnet, S., Wrangham, R.W., Muller, M.N., Otali, E., Hyeroba, D., Grindle, K.A., Pappas, T.E., Thompson,
M.E., Machanda, Z. and Watters, K.E., 2018. Lethal respiratory disease associated with human rhinovirus C in wild
chimpanzees, Uganda, 2013. Emerging infectious diseases, 24(2), p.267.

Spencer et al. ILI Review page 29
COMPOSITION OF ILI literature review
NOTE: 55-74% (average 62%) of patients with ILI who were sampled had viruses detected (Sentilhes, Taylor, Galindo-Fraga, Nandi,
Varghese, Mahony, Graat, van Gageldonk-Lafeber, Van Beek, Van Asten)

Citation

Sentilhes, A.C., Choumlivong, K., Celhay, O., Sisouk, T., Phonekeo, D., Vongphrachanh, P., Brey, P. and Buchy, P., 2013. Respiratory virus
infectionsM.S.,
in hospitalized
children and adults
in Lao
PDR.
Influenza
other respiratory
viruses,D.,7(6),
pp.1070-1078.
Chadha,
Broor, S., Gunasekaran,
P., Potdar,
V.A.,
Krishnan,
A.,and
Chawla-Sarkar,
M., Biswas,
Abraham,
A.M., Jalgaonkar, S.V., Kaur, H.
and Klimov, A., 2012. Multisite virological influenza surveillance in India: 2004–2008. Influenza and other respiratory viruses, 6(3), pp.196203.
Laguna-Torres, V.A., Gómez, J., Ocaña, V., Aguilar, P., Saldarriaga, T., Chavez, E., Perez, J., Zamalloa, H., Forshey, B., Paz, I. and Gomez, E.,
2009. Influenza-like
illness
surveillance
Peru.
PloS
one,
4(7), p.e6118.
Nguyen,
D.N.T., Bryant,
J.E.,sentinel
Hang, N.L.K.,
Nadjm,inB.,
Thai,
P.Q.,
Duong,
T.N., Anh, D.D., Horby, P., van Doorn, H.R., Wertheim, H.F. and Fox,
A., 2016. Epidemiology and etiology of influenza-like-illness in households in Vietnam; it’s not all about the kids!. Journal of Clinical Virology,
82, pp.126-132.
Taylor, S., Lopez, P., Weckx, L., Borja-Tabora, C., Ulloa-Gutierrez, R., Lazcano-Ponce, E., Kerdpanich, A., Weber, M.A.R., de Los Santos, A.M.,
Tinoco, J.C. and Safadi, M.A.P., 2017. Respiratory viruses and influenza-like illness: epidemiology and outcomes in children aged 6 months to
10 years in a multi-country population sample. Journal of Infection, 74(1), pp.29-41.
Dia, N., Sarr, F.D., Thiam, D., Sarr, T.F., Espié, E., OmarBa, I., Coly, M., Niang, M. and Richard, V., 2014. Influenza-like illnesses in Senegal:
not only focus on influenza viruses. PLoS One, 9(3), p.e93227.
Freymuth, F., Vabret, A., Rozenberg, F., Dina, J., Petitjean, J., Gouarin, S., Legrand, L., Corbet, S., Brouard, J. and Lebon, P., 2005. Replication
of respiratory viruses, particularly influenza virus, rhinovirus, and coronavirus in HuH7 hepatocarcinoma cell line. Journal of medical virology,
77(2), pp.295-301.
Louie, J.K., Hacker, J.K., Gonzales, R., Mark, J., Maselli, J.H., Yagi, S. and Drew, W.L., 2005. Characterization of viral agents causing acute
respiratory infection in a San Francisco University Medical Center Clinic during the influenza season. Clinical Infectious Diseases, 41(6),
pp.822-828.
Fowlkes, A., Giorgi, A., Erdman, D., Temte, J., Goodin, K., Di Lonardo, S., Sun, Y., Martin, K., Feist, M., Linz, R. and Boulton, R., 2013. Viruses
associated with acute respiratory infections and influenza-like illness among outpatients from the Influenza Incidence Surveillance Project,
2010–2011. The Journal of infectious diseases, 209(11), pp.1715-1725.
Galindo-Fraga, A., Ortiz-Hernández, A.A., Ramírez-Venegas, A., Vázquez, R.V., Moreno-Espinosa, S., Llamosas-Gallardo, B., Pérez-Patrigeon,
S., Salinger, M., Freimanis, L., Huang, C.Y. and Gu, W., 2013. Clinical characteristics and outcomes of influenza and other influenza-like
illnesses in Mexico City. International Journal of Infectious Diseases, 17(7), pp.e510-e517.
Nandi, T., Khanna, M., Pati, D.R., Kumar, B. and Singh, V., 2018. Epidemiological surveillance and comparative analysis of patients with
influenza like illness and other respiratory viruses. International Journal of Infectious Diseases, 73, p.203.
Varghese, B.M., Dent, E., Chilver, M., Cameron, S. and Stocks, N.P., 2018. Epidemiology of viral respiratory infections in Australian workingage adults (20–64 years): 2010–2013. Epidemiology & Infection, 146(5), pp.619-626.
Mahony, J.B., Petrich, A. and Smieja, M., 2011. Molecular diagnosis of respiratory virus infections. Critical reviews in clinical laboratory
sciences, 48(5-6), pp.217-249.
BOLLAERTS, K., Antoine, J., Van Casteren, V., Ducoffre, G., HENS, N. and Quoilin, S., 2013. Contribution of respiratory pathogens to influenzalike illness consultations. Epidemiology & Infection, 141(10), pp.2196-2204.
Graat, J.M., Schouten, E.G., Heijnen, M.L.A., Kok, F.J., Pallast, E.G., de Greeff, S.C. and Dorigo-Zetsma, J.W., 2003. A prospective, communitybased study on virologic assessment among elderly people with and without symptoms of acute respiratory infection. Journal of clinical
epidemiology, 56(12), pp.1218-1223.
Buecher, C., Mardy, S., Wang, W., Duong, V., Vong, S., Naughtin, M., Vabret, A., Freymuth, F., Deubel, V. and Buchy, P., 2010. Use of a
multiplex PCR/RT-PCR approach to assess the viral causes of influenza-like illnesses in Cambodia during three consecutive dry seasons.
Journal of medical virology, 82(10), pp.1762-1772.
van Gageldonk-Lafeber, A.B., Heijnen, M.L.A., Bartelds, A.I., Peters, M.F., van der Plas, S.M. and Wilbrink, B., 2005. A case-control study of
acute respiratory tract infection in general practice patients in The Netherlands. Clinical Infectious Diseases, 41(4), pp.490-497.
van Beek, J., Veenhoven, R.H., Bruin, J.P., Van Boxtel, R.A., de Lange, M.M., Meijer, A., Sanders, E.A., Rots, N.Y. and Luytjes, W., 2017.
Influenza-like illness incidence is not reduced by influenza vaccination in a cohort of older adults, despite effectively reducing laboratoryconfirmed influenza virus infections. The Journal of infectious diseases, 216(4), pp.415-424.
van Beek, J., Veenhoven, R.H., Bruin, J.P., Van Boxtel, R.A., de Lange, M.M., Meijer, A., Sanders, E.A., Rots, N.Y. and Luytjes, W., 2017.
Influenza-like illness incidence is not reduced by influenza vaccination in a cohort of older adults, despite effectively reducing laboratoryconfirmed influenza virus infections. The Journal of infectious diseases, 216(4), pp.415-424.
van Asten, L., van den Wijngaard, C., van Pelt, W., van de Kassteele, J., Meijer, A., van der Hoek, W., Kretzschmar, M. and Koopmans, M.,
2012. Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and
parainfluenza in elderly persons. The Journal of infectious diseases, 206(5), pp.628-639.
Iwane, M.K., Edwards, K.M., Szilagyi, P.G., Walker, F.J., Griffin, M.R., Weinberg, G.A., Coulen, C., Poehling, K.A., Shone, L.P., Balter, S. and
Hall, C.B., 2004. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and
parainfluenza viruses among young children. Pediatrics, 113(6), pp.1758-1764.
*Rhinovirus included other enteroviruses in many studies.

year(s) of study

Sample Size

9/2004-12/2008

% of 6835 ILI 2688 positive

2008-2013

2/2010-8/2011
2012-2013

1999-2002

Jan -Mar 2002

945 % of 271 positive
% of 3717 ILI. 2958
6266 pos.
1038 pos.
patients
% of 1678 viruses

5258 total
266 diag.
acute resp
infection

8/2010-7/2011

103 positive

2010-2013

population
hospitalized for
acute lower
respiratory
infection

13.00%

ILI and SARI

34.80%

ILI

17.00% NA

6 mo- 10 yrs

children w/ ILI

15.80%

all

ILI patients

19.00%

hosp. children

18.30%

ARI diagnosis

2443 all

rhinovirus*

4.00%
NA

35.00%
NA

1.80% NA

RSV

coinfection

26.00%
NA

0.50%

8.00%

0.60%

0.90%

28.00%

3.00% NA-all single

9.80%

5.60%

41.50%

9.70% not clear

22.00%

2.00%

19.00%

9.00% not clear

6.50%

1.90%

15.10%

44.00% not clear

52.40%

23.30%

1.90%

23.30%

11.60%

ARI & ILI

21.20%

5.70%

7.30%

21.10%

24.00%

9.00%

14.40%

25.30%

ILI

100 % of 100 patients

all

ILI

20-64

36.78% NA
NA

all

2.83%
1.30% NA

NA

NA

NA

NA

NA

NA

Oct 98-Oct 99

107 episodes in 97
652 subjects

2005-2007

234

83 all

ILI

NA

2000-2003

645

156 all

ARTI incl ILI

NA

ILI

7.00%

55.00%

NA

8.00%

ALL

>=60 yrs

HcoV

6.00%

4.43% NA

ILI only

821 viruses in 678
913 subjects

??

adenovirus

all

>=18

3201 1789 positive

influenza A/B

all, med 13

1797 <18

4212

same

2004-2008

age range

% of 162 positive.
140 single virus
detected; 22
292 coinfections detected all, med 2.2
all, med
13928 only influenza
14.66

8/2009-10/2010

6/2006-5/2008

Positive samples

% of ILI
patients with
detected
viruses

62.30%

6.20% not clear

10.30%

11.90%

5.66% NA
18.60%

64.00%
68.85%

3.10% not clear

55.80%

54.42%
NA

0.00%

17.00%

32.00%

0.00%

3.60%

21.70%

43.40%

7.20% yes

NA

7.00%

24.00% NA

58.00%

3.00%

58.00%

2011/12

1992

141 60-89

ILI

18.90% NA

18.20%

8.40%

4.90%

64.90%

2012/13

2368

260 60-89

ILI

34.20% NA

11.30%

21.10%

6.50%

73.80%

361 < 5

hosp ARI children

20.00%

61.00%

2000-2001

592

3.00%

